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ABSTRACT

Protein S-nitrosylation, the covalent modification o f a cysteine sulfhydryl group
by nitric oxide (NO), plays a critical role in post-translational modification (PTM ) that
regulates a large variety o f cellular functions and signalling events. The nitrosylation
state changes with oxidative damage and is involved in variety of cancers and
neurodegeneration diseases.
Three technologies were developed for nitrosylated protein detection and
identification. Capillary gel electrophoresis with laser induced fluorescence (CGE-LIF)
detection was used for the detection and quantitation o f nitrosylated proteins. A twodimensional micro-electrophoresis (2D //-CE) separations system was also built to detect
nitrosylated proteins via poly (methylmethacrylate) microchips. Proteomics following
nitrosylated proteins enrichment was used for identification o f protein S-nitrosylation.
The CGE-LIF method, with a limit detection o f 1.3 picomolar (pM) concentration
o f nitrosothiols in nanograms o f proteins, is the lowest limit o f detection o f nitrosothiols
reported to date. Dylight 488 maleimide was used to specifically label thiol group (SE1)
after switching the S-nitrosothiol (S-NO) to SH in cysteine using the “fluorescence
switch” assay. In vitro nitrosylation model-BSA subjected to S-nitrosoglutathione
(GSNO) optimized the labeling reactions and characterized the response o f the LIF
detector. The direct application o f this m ethod was demonstrated in monitoring protein
nitrosylation damage in menadione (MQ) mediated human colon adenocarcinoma cells

(HT-29). The nitrosothiol amounts in 200 ,uM MQ treated and untreated cells are
14.8±0.2 and 10.4±0.5 pmol/mg o f proteins, respectively. In addition, also depicted are
nitrosylated protein electrophoretic profiles o f brain cerebrum o f five-month-old AD
transgenic (Tg) mice model. In the Tg mice brain, 15.5±0.4 pmol o f nitrosothiols/mg o f
proteins was quantified while the wild type contained 11.7±0.3 pmol/mg proteins. The
methodology is validated to quantify low levels o f S-nitrosylated protein in complex
protein mixtures from both physiological and pathological conditions.
Compared with the conventional protein separation method, microfluidics has
been widely used for development o f novel tools for separation of protein mixtures.
Sodium dodecyl sulphate micro-capillary gel electrophoresis (SDS //-CG E) and
microemulsion electrokinetic chromatography (M EEKC) were used for the 1D and 2D
separations, respectively. The effective separation lengths for both dim ensions were ten
mm, and electrokinetic injection was used with field strength at 200V/cm. A fter 80
seconds separation in the ID CGE, fractions were successfully transferred to a second
MEEKC dimension for a short ten-seconds separation. This 2D pi-CE separation was
first demonstrated by resolving five standard proteins with a molecular weight (MW)
ranging from 20 to 64 kDa. A high peak capacity 3D landscape image o f nitrosylated
proteins from HT-29 cells before and following MQ treatment to induce oxidative stress
is also presented. Additionally, to illustrate the potential o f the 2D p-CE separation
method for rapid profiling o f oxidative stress-induced biomarkers implicated in AD
disease, the nitrosylated protein fingerprints from 11 -month-old AD transgenic mice
brain and its age matched control were also generated. This is the first known report on
2D profiling o f nitrosylated proteins in the biological samples on the microchip. The

characteristics o f this biomarker profiling will potentially serve as the screening for early
detection o f AD.
The proteomics study revealed protein S-nitrosylation in the MQ treated human
colon adenocarcinoma, HT-29 cells. Its profile o f S-nitrosylated proteins was compared
to a control cell line not exposed to MQ. A total o f 20 proteins were modified by
nitrosylation in MQ-treated HT-29 cells and at least ten nitrosylated proteins were
increased by exposure to MQ. Seventeen o f the 20 proteins are novel targets o f Snitrosylation not previously reported. These proteins include cytoskeletal and signaling
proteins, metabolic enzymes, chaperones, and redox-and differentiation-related proteins.
These results broaden knowledge o f therapy targets.
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CHAPTER 1

INTRODUCTION

1.1

Central Hypothesis

The central hypothesis in this dissertation is that oxidative-stress induced protein
S-nitrosylation profiling increases in both biological brain tissues and cells. A corollary is
that an increase in nitrosylated protein levels is higher in Alzheim er’s disease (AD)
transgenic mice brain tissues than in the wide type controls. A second corollary is that
M Q-treated HT-29 cells show more protein S-nitrosylation than untreated cells.
First, the hypothesis was tested using AD transgenic mice model (B 6 Cg-Tg).
Carrying both the Swedish amyloid precursor protein mutation (APP) and exon 9 deletion
o f the PSEN1 gene, the B 6 Cg-Tg mouse is a valuable model to study the pathological
alterations in AD. It always develops amyloid plaques at six to seven months o f age.
Second, oxidative protein nitrosylation damage mediated by menadione (M Q), a redox
cycling quinone in human colon adenocarcinoma cells (HT-29) was monitored.
Three technology needs were addressed: (i) Detecting and quantifying
nitrosylated proteins by capillary gel electrophoresis with laser induced fluorescence
detection (CGE-LIF), (ii) Using the 2D micro-electrophoresis method for the separation
o f complex protein samples and detection o f nitrosylated protein biomarkers using a poly
(methylmethacrylated) (PMMA) microchip, and (iii) Identifying o f nitrosylated proteins.

1

1.2

Aims

The overall goal o f this dissertation was to quantify and identify the major
nitrosylated proteins as oxidative stress biomarkers in A lzheim er’s disease (AD)
transgenicmice model (B 6 Cg-Tg) and HT-29 cells. Specifically, this goal could be
divided into three main specific aims (Figure 1-1):
(i) Develop a quantitative method to detect and quantify nitrosylated proteins (SNO) from MQ-treated HT-29 cells and AD transgenic mice cerebrum using the CGE-LIF
instrument.
(ii) Perform 2D separation o f nitrosylated proteins from MQ-treated HT-29 cells
and AD transgenic mice brain tissue by using in-house laser-induced fluorescence
detection system.
(iii) Identify nitrosylated proteins o f M Q-treated HT-29 cells via a proteomic
method.

P r u t ’ in c n f r o ,1 it o n ui uc
A ^ n e m t r ' 1 di*i* is» fA [J id
o x id a tiv e s tr e s s

SLPAPATION
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CGE-LIF m e th o d
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HT 2 9 c e lls a fter M Q

n itrosylation in AD Tg m ice

*r. i t n i
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1.3

Outline

This dissertation consists o f six chapters. Background (Chapter 2) reviews the
general understanding o f different areas, including free radical theory, protein Snitrosylation, analytical techniques, and mass spectrometry. In Chapter 3, a quantitative
method was developed to detect the nitrosothiol content in biological samples based on
capillary gel electrophoresis with laser induced fluorescence detection (CGE-LIF).
Chapter 4 describes an in-house built LIF system to detect S-nitrosothoils in complex
biological samples. This separation is based on 2D micro-electrophoresis method by
using PMMA microchips. Chapter 5 describes a proteom ic strategy, based on affinity
enrichment o f nitrosylated proteins to identify protein S-nitrosothoils in the M Q-treated
HT-29 cells. Results found ten nitrosylated proteins increasing in the M Q-treated HT-29
cells compared to the untreated ones. Finally, Chapter

6

summarizes the findings o f

Chapters 3, 4, and 5. It also makes suggestions for future directions in oxidative stress
induced biomarker development.

CHAPTER 2

BACKGROUND

2.1
2.1.1

Protein S-nitrosylation

Post-translational Modifications
Post-translational modifications (PTMs) are defined as the series o f chemical

reactions whereby a newly synthesized polypeptide chain is converted to a functional
protein. A common characteristic o f PTMs is that the accompanying change in amino
acid structure produces the corresponding change in the formula weight o f that amino
acid relative to the original, unmodified residue.
Protein S-nitrosylation is one o f the most commonly studied post-translational
modifications. Nitrosylated proteins have become the biomarkers o f oxidative damage
under conditions o f oxidative stress, aging and disease.
Researchers have shown that protein S-nitrosothiols content has been previously
reported in organs, including brain tissue, kidney, liver, lung [1-4]. Other reports identify
nitrosylated proteins in different types o f cells, such as mesangial, vascular smooth
muscle, endothelial and HeLa cells [5-8],
2.1.2

Formation o f Protein S-nitrosothiols
There are four major m echanisms to potentially form the nitrosothiol (SNO)

group in a biological system (Figure 2-1): (1) Nitric oxide (NO) can react with O 2 to

4

5

form dinitrogen trioxide (N 2O 3), which is considered to be the main S-nitrosylating
species due to its powerful electrophilicity[9]. (2) Peroxynitrite (ONOO'), the product
between NO and superoxide (O ’), can react with thiols to form S-nitrosothiols [10, 11].
(3) Transnitrosylaton between glutathione (GSH) and RSNO leads to the formation o f Snitrosoglutathione (GSNO) [11-13]. (4) S-Nitrosothiols can be formed from the reaction
o f nitrous acid (HONO) with thiols in an acidic environment, potentially occurring in the
gastro-intestinal tract [14, 15]. However, it is not clear which o f these mechanism s more
closely resembles in vivo physiological S-nitrosylation [16].

♦NO

P-SH '

GSH

ONOO

GSNO
S-nitros(y!)ation

HONO
Figure 2-1: Four major m echanisms to form protein S-nitrosylation.

2.1.3

Techniques for M easuring Protein
S-nitrosothiols
Currently, a number of “indirect” methods are used for the quantitative

measurement o f nitrosothiols, which either requires cleavage o f the S-NO bond, followed
with NO level measurement or replacement o f the S-NO with another detectable tag. One
widely utilized method is the colorimetric Saville assay [17]. NO+ is displaced from the
thiol by mercuric chloride in the presence o f sulphanilamide and then reacts with N -(l-

6

naphyl)-ethylenediamine. The reaction product, a colored azo dye, can be detected
spectrophotometrically at 540 nm. This method has a limit o f detection (LOD) around
500 nM [18]. However, this LOD is above physiological levels o f nitrosothiols, which
limits the application o f the technique to quantitative studies o f nitrosothiols from
biological samples.
Chemiluminescence assay has also been developed for S-NO measurement [19].
After cleavage o f the S-NO bond through either photolysis or chemical reduction, the
released NO reacts with ozone to form N O 2 *, which decays to NO 2 with the production
of light. This method has good sensitivity with an LOD o f 2 picomoles [19]. However,
the technical challenges lie in the equal mixing o f the test gas flow with the ozone [18].
Additionally, although the photolysis method consistently gives quantitative measures,
the NO yields by chemical tri-iodide reduction chemiluminescence assay are generally
low and difficult to reproduce [2 0 ].
A fluorescence method for the indirect detection o f SNOs using
spectrofluorometry to measure the status o f NO has also been reported [21, 22]. The SNO bonds are cleaved with HgCL, and the newly formed NO is monitored from its
reaction with 4, 5-diaminofluorescein (DAF) to yield a fluorescent triazolofluoroscein
(excitation/emission=485/520 nm) [19].The LOD o f this method reaches 5nM [21].
All the methods described above are not compatible with the analysis o f small or
biological samples, such as those obtained from needle biopsies, single cells or tissues. In
order to detect and quantitate nitrosothoils from these samples, a more sensitive method
with lower LOD is required. The method developed will be discussed in Chapter 3. This
new method may aid in developing methods for rapid analysis o f protein S-nitrosylation
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in smaller or biological samples. In addition, m icrofluidics have been widely used for the
development o f novel tools for separation o f protein mixtures. To resolve more
nitrosylated proteins in the biological samples, the 2D electrophoresis separation method
will be discussed in Chapter 4.
2.1.4

Techniques for Identification of
Nitrosylated Proteins
In addition to measuring the protein S-nitrosylation amount, it is also important to

identify nitrosylated proteins and the sites at which nitrosylation occurs. Nitrosylated
proteins have been identified in several ways. These approaches can be generally divided
into two branches: direct methods and indirect methods.
Direct detection o f protein S-nitrosylation involves immunohistochemistry by the
use of an SNO-specific antibody to detect in vivo protein S-nitrosylation [23].
Conventional methods such as immunoprecipitation, 2D-gel electrophoresis or western
blot are generally not preferable for protein S-nitrosylation because the S-NO bond is
degraded in the SDS-PAGE step [24]. However, the use o f a biotin switch assay coupled
with these methods can indirectly detect the changes in the protein S-nitrosylation status
under different biological conditions [25].
Recently, more “indirect” methods are being developed for the quantitation o f
nitrosothiols. These methods measure either the newly formed NO level after the S-NO
bond is cleaved, or another detectable tag which replaces the S-NO group. One widely
utilized method is the Saville assay [17]. The mechanism o f this method is to replace
N O + from the thiol group by mercuric chloride in the presence o f sulphamilamide and
then react with N -(l-naphyl)-ethylenediamine. The reaction product, a colored azo dye,
can be detected by spectrophotometrically at 540nm [20]. Biotin switch assay (B SA ) is
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another widely used methods for detecting protein S-nitrosylation [25]. It utilizes a
sulphydryl-specific biotinylating agent to react with free cysteine that is created from
nitrosothiol group (S-NO) to form the biotin tag. Then, this method can couple with
immunoblotting, 2D-gel electrophoresis, or fluorescence gel electrophoresis to detect
changes in protein S-nitrosylation status under different biological conditions. Such
methods can effectively determine the total level o f protein S-nitrosylation present in the
biological sample, but they are unable to identify specific S-nitrosylated proteins.
For the identification o f nitrosylated proteins sites in the complex biological
samples, approaches based on mass spectrometry (MS) are required. Due to the lability to
this type of modification, the direct detection o f MS is still quite problematic. A couple o f
indirect methods have been developed for protein identification. The previously widely
used method is the biotinylated proteins purified by avidin affinity chromatography after
BSA and then followed by 2D-gel electrophoresis for MS analysis [5, 7, 26-30]. Few Snitrosylation proteins have been identified by this approach due to its low abundance and
to the low recovery o f S-nitrosylated peptides from in-gel digestion. A new method, SNO
Site Identification (SNO), introduced a proteolytic digestion step before avidin capture
[31]. It allows the selective isolation o f peptides that previously contained S-nitrosylated
Cys residues and 68 S-nitrosylated peptides from 56 rat cerebellar proteins that were
identified in this study. In this way, only the modified peptides are enriched and eluted
for the following identification by MS: this is fundamental improvement because only the
localization o f the modified residue can confer high confidence in the results. However,
two disadvantages are shown in this method. First, the identification o f a protein depends
on MS/MS-based sequence information inferred from a single peptide ion. Second, a
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relative large amount (lg ) o f starting tissue/cells is required. Camerini et al. used an Nterminally modified His-tag to selectively label the thiol group (SH) reduced by
nitrosothiol group (SNO) instead o f biotin tag [32], From this approach, the author got 28
modified Cysteine moieties from 19 proteins. Forrester et al. recently developed a method
named S-nitrosothiol resin-assisted capture (SNO-RAC), which requires fewer steps
because it combines the '‘labeling ” and “pull dow n” steps from the BSA into one step
[33]. This approach can detect 44 novel SNO sites in E. coli [33]. The author pointed out
that this method appeared to be more sensitive than the BSA for high m ass proteins, and
at least as sensitive as the BSA for proteins sm aller than 100 kDa. However, Liu et al.
revealed that both the BSA and RAC approaches were not effective at S-nitrosylation site
identification [24], They did not address the issue o f accurate site localization, especially
when more than one cysteine was present in an identified peptide sequence. They
presented a novel and robust method for site-specific high-throughput identification o f
protein S-nitrosylation (SHIPS) in complex protein mixtures. The SHIPS approach
utilized a cysteinyl affinity resin to pull down ascorbate reduced S-nitrosylated peptides,
rather than S-nitrosylated proteins. Two commonly used alkylation agents, acrylamide
and iodoacetamide, were employed to differentiate free and disulfide-bonded cysteine
form reduced S-nitrosylated cysteine [24], A total o f 162 S-nitrosylation sites were
identified and an S-nitrosylation m otif was revealed in this study.
Even though all these studies successfully identified nitrosylated proteins, none of
them identified the oxidative stress induced nitrosylation in HT-29 cells. This dissertation
developed a proteomic strategy to identify nitrosylated proteins in HT-29 cells before and
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after MQ treatment. The strategy allowed identifying the proteins that are truly affected
by oxidative protein nitrosylation damage mediated by MQ.

2.2

Protein Separation

Protein separation involves reducing the complexity o f the protein mixture by
sorting them into smaller purified protein compartments. The goal is to obtain individual
protein plugs or spots, so that each protein can be easily identified without interference
from another protein. Separating a complex protein mixture into individual proteins is
usually impractical, especially when dealing with a complex proteome that contains
numerous proteins.
2.2.1

Capillary Gel Electrophoresis for
Analysis o f Proteins
In order to quantitate nitrosothiol levels o f proteins, the previous m ethods for

measuring protein S-nitrosylation discussed in Section 2.1.2 are not sensitive enough for
investigation o f biological samples. W ith a highly sensitive detection system such as
laser-induced fluorescence (LIF), capillary electrophoresis is chosen because o f the low
limits o f detection (LOD) achieved.
2.2.2

Microchip Separation
The conventional method o f 2D separation involves a charge-based separation

where proteins are separated based on their isoelectric points followed by a size-based
separation, where proteins are separated according to their molecular weight [34], This
technique has capability o f resolving 5000 proteins [34, 35], and 10,000 proteins can be
resolved by large sized 2D-gels [36]. However, this method has some major issues, such
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as poor reproducibility, and time consuming and labor-intensive experimental
procedures.
M icrochips offer various advantages, such as short analysis times, minimal
sample volumes, reduced dead volumes, high peak capacities and easy coupling o f
multiple separation channels [37], Although the common modes o f protein CE separation
have been adapted to the chip format, the multidimensional approaches are still in
progress. N umerous groups have reported different microchip 2D systems for protein
separations. In the former, Soper and co-workers employed SDS micro-capillary gel
electrophoresis (SDS //-CGE) and /^-MEKC electrophoresis in the ID and 2D,
respectively, reporting to sort ten model proteins [38] and serum proteins [39] using a
PMMA microchip. The 2D electrophoresis system could generate a peak capacity o f
-2,600 in fewer than 30 minutes for proteins isolated from fetal calf serum (FCS). The
same group also combined the SDS //-CG E with micro-emulsion electrokinetic
chromatography (//-MEEKC) and reported //-MEEKC in the 2nd dimension was found to
produce higher peak capacities (481 ± 18) compared to yU-MEKC (332 ± 17) [40],

2.3

Protein Identification

Proteomics is the study o f the entire proteins in a given organism, whereas the
proteome is a catalogue o f the proteins in a specific organism that are coded by the
genome. Proteomics is concerned with the determination o f structures, expressions,
interactions, and functions, which includes activities, roles and locations o f proteins in an
organism. The original definition o f the proteome views the proteome as the protein
complement o f the genome; therefore, it does not account for the numerous posttranslational modifications and the ever-changing state o f proteins. Proteomics can then
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be defined as the comprehensive analysis, including the determination o f structure,
modifications, expression levels, localization and protein-protein interactions, within a
given organism, tissue, cell, or biological fluid at a specified time.
In general, two approaches for protein identification in proteomics are recognized,
namely, bottom-up and top-down strategies. The top-down and bottom-up strategies are
complementary to each other in terms o f proteomic coverage.
2.3.1

Top-Down Strategy
In the top-down strategy, the intact protein mixture is directly subjected to a

proteolytic digestion without protein separation followed by separation o f the peptides
with the isolated peptides submitted for mass analysis. The m ain advantage o f this
method is a protein mixture is digested to generate peptides, which are easier to analyze
compared to a complex protein sample that contains a mixture o f very small or very large
proteins. The main disadvantage o f this methodology is its low er efficiency in protein
identification since it lacks an efficient protein separation technology that can be easily
interfaced to the mass spectrometer.
2.3.2

Bottom-Up Strategy
In the bottom-up strategy, first, a protein mixture is separated. Then the resolved

proteins are enzymatically broken into peptides before being sent into a mass
spectrometer for mass analysis. There are several advantages to using this strategy. First,
proteins can be visualized immediately after gel separation before the protein digestion.
Second, protein profiles o f the sample can be generated since a gel separation is
performed. Third, fewer peptides are fed into the MS,resulting in simple peptide mass
spectra compared to the MS spectra obtained from a top-down strategy.
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2.3.3

Peptide Preparation
The most basic task o f proteomics is the detection and identification o f proteins

from a biological sample. In this dissertation, the top-down strategy was used for
nitrosylated proteins identification. It began with the protein digestion after protein
purification with “biotin switch assay” method, followed by nitrosylated proteins
enrichment and mass analysis typically by liquid chromatography-tandem mass
spectrometry (LC-MS/MS).
For protein digestion, trypsin is used to convert proteins to peptides. A fter this
step, the peptides are always separated and go to M S analysis. SDS-PAGE is often used
to separate complex protein mixtures. Slices can be excised from the whole lane o f gel,
and proteins from each gel slice can be analyzed separately by high perform ance liquid
chromatography followed by mass spectrometry (HPLC-M S). Alternately, gel-free MSbased proteomics, such as affinity chromatography, are occupying a central role in
biological research. In this dissertation, streptavidin agarose was used to enrich
biotinylated nitrosylated proteins after trypsin digestion.
2.3.4

Mass Spectrometry Analysis
M ass spectrometry has been widely used as an analytical technique since its

establishment more than one hundred years ago. Currently, many laboratories are
experimenting with the application o f MS as an instrumental tool for analytical and
structural studies o f proteins.
Ionization source, analyser, detector, data processor and vacuum pumps are the
main components in a mass spectrometer. The analyser and the detector must be under
vacuum. In the late 1980s, two new ionization techniques, electrospray ionization (ESI)
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and matrix-assisted laser desorption/ionization (M ALDI), were developed for the first
time for the acquisition o f mass spectra with minute quantities o f peptides and proteins.
In ESI, ions are formed at atmospheric pressure, w hile ions in MALDI may be generated
either at atmospheric pressure or under vacuum conditions. ESI is commonly used for the
top-down strategy. The reason for that is liquid chromatography (LC), used in the
separation o f the peptides, couples naturally to ESI due to the ability o f continuous
sample infusion into the ES ion source.
The analyser is the part o f the mass spectrometer where the separation process
takes place. A mass spectrometer may be constructed with multiple analysers, depending
on the task they will be used for. Instruments composed o f two or more mass analysers
coupled together are known as tandem mass spectrometers.

CHAPTER 3

HIGHLY SENSITIVE DETECTION OF S-NITROSYLATED
PROTEINS BY CAPILLARY GEL ELECTROPHORESIS
WITH LASER INDUCED FLUORESCENCE

3.1

Introduction

S-nitrosylation (also referred to as nitrosation) o f protein is a post translational
modification (PTM) o f thiols on cysteines [41]. It is essential in cellular function and
signaling regulation [9, 11, 42-44] and serves as a biom arker in many diseases including
Alzheimer’s disease, Parkinson’s disease, H untington’s disease, diabetes, and stroke [1,
45-48],
Accurate and sensitive methods to detect and quantify low levels o f S-nitrosylated
proteins in complex protein mixtures from both physiological and pathological conditions
are required in order to fully understand the range and extent o f this modification. In this
paper, a new quantitative method to detect SNOs by capillary gel electrophoresis with
laser induced fluorescence detection (CGE-LIF) is developed. Among the commercial
detection modes developed for CE, LIF is one o f the m ost sensitive detection techniques
[49]. Here, a fluorescence switch method derived from the biotin switch assay is used to
label the nitrosothiols [50, 51].'The procedure consists o f the derivatization o f
nitrosothiols into free sulfhydryl groups followed by specific labeling o f sulfhydrylcontaining proteins with Dylight 488 maleimide (Ex/Em = 493/528 nm). The
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derivatization process includes alkylation with methyl-methanethiosulfonate (M MTS) to
block all sulfhydryl groups followed by the reduction o f nitrosothiols to newly formed
sulfhydryl groups. Then the Dylight 488 fluorophore labels nitrosylated proteins, which
are monitored using CGE-LIF. This procedure proves to be adequate for analyzing
nanogram numbers in protein samples with picomolarlevels o f nitrosothiols in less than
15 minutes.
This study also demonstrates the direct application o f the above mentioned
method in monitoring oxidative protein nitrosylation damage mediated by menadione
(MQ), a redox cycling quinone in human colon adenocarcinoma cells (HT29). MQ has
the redox-cycling capacity to acrylate cellular nucleophiles such as DNA and proteins,
with mitochondrion considered as the main redox site. MQ can mediate apoptosis
through formation o f the toxic species, the semiquinone (SQ ) radical, which is formed by
mitochondrial NADPH-ubiquinone oxidoreductase (ubQO) through one-electron
metabolism. The SQ can then participate in redox cycling through reaction w ith O 2 to
generate the superoxide anion (O 2 ") and concomitantly regenerate M Q[52-54], The
electropherogram results indicated that a wide distribution o f molecular weight (MW) o f
proteins were nitrosylated. In addition, it is observed that exposure to MQ caused an
increase in protein nitrosylation damage.
Also examined was the nitrosylation level in a minuscule amount o f brain
cerebrum tissue from an Alzheimer’s disease (AD) transgenic mice model (B 6 Cg-Tg).
Carrying both the Swedish amyloid precursor protein mutation (APP) and exon 9 deletion
of the PSEN1 gene, the B 6 Cg-Tg mouse is a valuable model to study the pathological
alterations in AD. These results not only depicted an electrophoretic profile o f
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nitrosylated proteins in brain tissue, but also proved capable o f analyzing a minuscule
amount o f tissue using the CGE-LIF method.

3.2
3.2.1

M aterial and Methods

Materials and Reagents
sodium dodecyl sulfate (SDS), 2-[4-(2-hydroxyethyl)piperazin-l-yl]

ethanesulfonic acid(HEPES), tris (hydroxymethyl)-aminomethane, tricine, (+)-sodium Lascorbate, ethylenediaminetetraacetic acid (EDTA), albumin bovine serum (BSA),
methanol, sodium hydroxide, hydrochloric acid, neocuproine, S-methyl
methanethiosulfonate (MMTS), dextran from Leuconostocmesenteroides(average MW
64,000-76,000), trichloroacetic acid (TCA), menadione (2-m ethyl-1,4-naphtoquinone;
MQ) were all purchased from Sigma. Amicon ultra-4 (MW cutoff o f 3000 Da) was from
Millipore. DyLight 488 Maleimide and dimethyl sulfoxide (DMSO) was from Thermo
Scientific. Ultra Trol Dynamic Pre-Coat LN was obtained from Target Discovery.
Sulphanilamide was purchased from A lfa Aesar. N -l-Naphthylethylenediam ine
hydrochloride was obtained from TCI. S-Nitrosoglutathione(GSNO) was purchased from
Calbiochem. The bicinchoninic acid (BCA) assay was from Pierce. HEN buffer was
composed o f 250 mM HEPES, 1 mM EDTA, and 0.1 mM neocuproine at pH 7.7. HENS
buffer was prepared in HEN buffer with the addition o f 1% SDS. The separation buffer
consisted o f 20 mM Tris, 20 mM Tricine, 0.5% SDS at pH 8 . The sieving matrix buffer
was prepared in the separation buffer with 15% dextran.
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3.2.2

Capillary Electrophoresis with Laser
Induced Fluorescence Detection
A commercial capillary electrophoresis instrument, Beckman Coulter P/ACE

MDQ system (Fullerton, CA), was used for the analysis o f protein nitrosylation. For
excitation, the LIF detector used an argon-ion laser (488 nm line, 3 MW ) that was
directed to a detector window in the capillary using fiber optics. A 520DF20 bandpass
filter (-510-530 nm) was used to select the Dylight 488 fluorescence before the photo
multiplier tube (PMT). The PMT output signals were sampled at 4 Hz.
Separations were carried out using a 31-cm-long, 50-^m -i.d., 361-«m-outer-o.d.
fused-silica capillary. UltraTrol LN, a class o f linear polyacrylamide made o f Nsubstituted acrylamide copolymers, was used for precoating the capillary walls. This
procedure decreases the electroosmotic flow (EOF) and inhibits protein binding to the
inner wall o f the capillary. The sample was injected hydrodynamically at 1 lkP a for 4
seconds into the capillary containing the sieving matrix buffer. Separations were
performed at -570 V/cm. The capillary was reconditioned between consecutive runs with
sequential pressure-driven flushes (20 psi) o f 0.5 M sodium hydroxide for five minutes,
H 2O for three minutes, the dynamic coating reagent UltraTrol LN for two minutes, the
separation buffer for two minutes, and the sieving m atrix buffer for four minutes [55, 56].
3.2.3

In Vitro Nitrosylation o f BSA and SNO
quantification by Saville-Griess Assay
GSNO can react with thiol groups to yield nitrosothiols. Briefly, the BSA solution

(7.5 mg/mL) was incubated with the NO donor GSNO (500 //M ) in darkness for 30
minutes with constant rotating [8 ]. Nitrosylated protein level from the in vitro BSA test
model was quantified using Saville-Griess assay. Briefly, mercury displacement o f N O
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from nitrosylated BSA was achieved by ten m inutes o f incubation with 100 gM mercury
chloride. The remaining GSNO was removed via Slide-A-Lyzer Dialysis Cassettes (10K
M W CO, Pierce) overnight. The buffer for dialysis was BupH™ Borate buffer Pack
(Pierce). Nitrite levels were determined spectrophotomically after reaction with 100 /uL o f
Griess reagent (1:1 mixture o f 3% sulfanilamide in 0.4 M HC1 and 0.1% ./V-(l-naphthyl)
ethylenediamine in 0.4 M HC1) and quantified using absorbance at 540 nm and extinction
coefficient of 51 mM ’1cm ' 1 [57, 58],
3.2.4

Cell Culture and Incubation w ith MO
The human colon epithelial adenocarcinoma cell line HT-29 was purchased from

the American Type Culture Collection (M anassas, VA, USA). HT-29 cells were grown in
M cC oy’s medium supplemented with 10% fetal bovine serum, penicillin (100 units/mL),
and streptomycin (100 units/mL). HT-29 cells were maintained at 37°C in 5% CO 2
humidified incubator. One day prior to experimentation, HT-29 cells were plated in T75
flasks and exposed to a final concentration o f 200 gM MQ (freshly prepared) for 30
minutes in serum-free DMEM (Dulbecco’s M odified Eagle’s medium). Thereafter, cells
were washed and scraped into cold-PBS. The resulting pellet obtained upon
centrifugation at 1000 rpm (Centrifuge 5804 R, Eppendorf) was immediately frozen in
liquid nitrogen and used for further analysis o f nitrosylated proteins.
3.2.5

Protein Extraction from MO Treated Cells
The pellets o f HT-29 cells prepared from Section 3.2.4 were washed five times

with phosphate-buffered saline (PBS) and resuspended in 100 /iL water. The cells were
sonicated for 20 s in the power level o f 4 (550 Sonic Dismembrator from Fisher
Scientific). The suspension was centrifuged at 600xg (Centrifuge 5804 R, Eppendorf) for
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ten minutes. A 40 fih aliquot o f the supernatant was then used for “fluorescence switch”
assay. The untreated HT-29 cells followed the same procedure. The protein concentration
was measured by the BCA assay.
3.2.6

Isolation o f Brain Cerebrum from
AD Transgenic Mice Model
The cerebrum was isolated from the brain o f five-month old transgenic mice

(B 6 Cg-Tg) and its age-matched wild type (WT) control. Briefly, the cerebrum was
minced with scissors and suspended in isolation buffer (320 mM Sucrose, 10 mM Hepes,
1 mM EDTA). The minced tissue was homogenized and 100 juL homogenate o f each
sample (Tg and WT) was added with 40 //L 20% TCA followed with incubation for ten
minutes at 4 °C. After that, the solution was centrifuged at 10000xg (Labnet Prism™ R
Refrigerated Microcentrifuge) for five minutes at 4 °C and the supernatant was discarded.
The protein pellet was mixed with 50 fiL HENS buffer.
3.2.7

Fluorescence Switch Assay
Figure 3-1 shows the schematic o f fluorescence switch assay. This procedure

consists o f the derivatization o f SNOs into free sulfhydryl groups followed with highly
sensitive specific labeling o f sulfhydryl-containing proteins with Dylight 488 maleimide.
As the S-NO bond is light sensitive, all the experimental procedures were conducted in
the dark [8 , 11, 59]. Briefly, for the labeling reaction, a volume o f 5 juL nitrosylated BSA
prepared in Section 3.2.3 was incubated with 20 //Lblocking buffer (nine volumes

of

HEN buffer, one volume o f 25% SDS, 0.1 volum es o f 2 M MMTS stock solution in N,
N-dimethylformamide) at 50°C for 30 minutes with frequent rotating. To remove the
excess MMTS, an Amicon Ultra-4 centrifugal filter unit (3000 MW cut-off) was used.
The sample was centrifuged for three times at 4500xg for 20 minutes with the washing
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solvent, HEN buffer. The final volume after wash was around 60 //L. Then 2 piL freshly
prepared 50 mM ascorbate was added to reduce the nitrosothiol groups to thiols and the
incubation lasted for one hour at room temperature. For labeling the newly reduced free
thiol groups generated from the last reduction step, 4 juL o f 12.5 mM Dylight 488
maleimide was added into the solution, and the reaction proceeded overnight at room
temperature.

O
H3C

SH
SNO

S

S

CH3

,— S-S-CHj

O
MMTS

-SNO

s
•s

■s
■s

Ascorbate

I
•S- Biotin

Biotin-HPDP

s-s-c h 3
■SH

Figure 3-1: Schematic o f fluorescence switch assay coupled with CGE-LIF for
detecting and quantifying S-nitrosylated proteins. Fluorescence switch assay (Steps 13) includes blocking thiol group by MMTS, reducing nitrosothiol group with ascorbate
and labeling reduced free thiol by Dylight 488 maleimide. Finally, labeled proteins are
separated and analyzed by CGE-LIF.
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To remove the unreacted Dylight 488 maleimide dye from the sample, the sample
was centrifuged for a total o f six times at 4500xg for 20 minutes using the Amilcon filter
with 3000 MW cut-off [25, 60], The washing solvent was the CE separation buffer. After
removal o f excessive dye, 5 pL o f 20% SDS in separation buffer was added into a final
volume around 100 pL to saturate proteins. The derivatized and fluorophore labeled
solution was then diluted to 1, 0.5, 0.25, and 0.1 fold o f the original concentration with
separation buffer.
The procedure for nitrosylation labeling in HT-29 cells and B 6 Cg-Tg mice with
Dylight 488 maleimide was basically the same as the nitrosylated BSA,except for the use
o f 40 pL o f from both HT-29 cells and B 6 Cg-Tg mice cerebrum. The selectivity o f
labeling nitrosothiols using this fluorescence switch assay was studied by incubating
nitrosylated BSA with mercury chloride to displace the NO group prior to the procedure
o f the assay. Also, fluorescence switch assay without proteins and untreated BSA as a
negative control was performed individually with fluorescence switch assay and CGELIF to validate the specificity o f the assay to SNOs.
3.2.8

Data Analysis for CE
Igor Pro software (Wavemetrics, Lake Oswego, OR) was used to analyze

electropherograms, which provides intensity values at each migration time point. The
integrated fluorescence peak areas were measured to calculate the nitrosylated protein
amounts using the in-house-written Igor procedure, W ide Peak Analysis [55].
3.2.9

Validation o f Nitrosylated Proteins
CE Peaks Using Proteomics
The biotin switch assay was perform ed as described by Jaffrey and Snyder [25],

Briefly, the protein concentration was adjusted to 0.8 /^g/z/L using HEN Buffer (250 mM
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Hepes/NaOH pH 7.7, 1 mM EDTA, 0.1 mM neocuproine) and then incubated at 50 °C
for 30 minutes in blocking buffer (9 volumes o f HEN buffer, 1 volume o f SDS (25% w/v
in H 2O) and MMTS added to a final concentration o f 20 m M ) with frequent vortexing.
Acetone precipitation was performed to remove MMTS. The protein pellet was
resuspended in 0.1 mL HENS solution (HEN Buffer in 1% SDS) per mg protein,
followed by incubation with 2 mM biotin-HPDP and 2 mM ascorbate for lh at 25 °C.
A fter biotinylation to label S-nitrosylated proteins, biotin-HPDP was removed by acetone
precipitation and centrifugation, and the pellet was resuspended in HENS buffer as
above. The proteins were then trypsin digested overnight, and the resulting peptides were
desalted in a mixed-mode cation exchange column (MCX; Waters) followed by Sep-Pak
reverse-phase extraction prior to LC-electrospray ionization (ESI) MS/MS analysis [61].
For identifying nitrosylated proteins, the sample was divided into three equal
portions and analyzed by LC-MS/MS. Peptide mixtures were first separated on an
Agilent 1200 Capillary Series liquid chromatograph (Agilent Technologies, Palo Alto,
California, CA), and identified via pLC-ESI M S/M S on a hybrid linear ion trap-Orbitrap
mass spectrometer (LTQ-Orbitrap XL; Thermo Electron, San Jose, CA). MS/MS spectra
were acquired in a data-dependent acquisition mode that automatically selected and
fragmented the five most intense peaks by higher-energy collisional dissociation (HCD)
from each MS spectrum generated.
MS/MS spectra were searched using human International Protein Index protein
sequence data base (version 3.74, 39,906 protein sequences; European Bioinformatics
Institute). The dataset, built from the Swiss-Prot, TrEMBL, Ensembl and RefSeq
databases, offers complete nonredundant data sets representing a set o f human proteomes
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[62]. The database searching was performed using Proteome Discovery (version 1.0,
Thermo Fisher, San Jose, CA) and M ascot (version 2.2.02, Matrix Science, London, UK)
with the following parameters: trypsin as digestion enzyme; M ethylthiolation (C),
Oxidation (M) and Biotin-HPDP (C) were set as variable modifications.

3.3
3.3.1

Results and Discussion

Fluorescence Switch Assay Coupled
with CGE-LIF
The Dylight 488 maleimide was used to label the reduced nitrosothiol group after

blocking the free thiols in the nitrosylated proteins. The mechanism o f this m ethod
resembles biotin switch assay, which is widely used in the study o f nitrosylation
proteomics using mass spectrometry [25]. One possible question in fluorescence switch
assay is the possibility o f nonspecific reduction o f SNOs by ascorbate. In this regard,
Giustarinie/ al. have expressed concern that the ascorbate treatment may reduce 5,5’dithiobis (2-nitrobenzoic acid) (DTNB)and the protein mixture, giving rise to a
significant false-positive signal [63], However, m ost recently Forrester et al. challenged
this opinion with the following reasons: first, DTNB is not representative o f biological
disulfides since its disulfide bonds are highly electrophilic. The high electrophilic bonds
can be facilitated by ascorbate [64], Second, ascorbate could not reduce intramolecular
protein disulfides under denaturing conditions, even if protein mixture disulfides may be
cleaved by ascorbate [63], Third, the reduction o f disulfide bonds by ascorbate is highly
thermodynamically unfavorable since the oxidation-reduction potential o f cysteine
(CSH)/cystine (CSSC) is found to be -220 mV and that o f the ascorbic acid is 70 mV[65,
6 6 ].Lastly,

Giustarinie/ al. did not perform the biotin switch assay. However, Forrester et
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al. revealed that the reduction o f ascorbate to the S-NO bond is unique among Cys
oxidation products after biotin switch, and the authors conclude that this reaction confers
specificity to the biotin switch assay [67], as evidenced by previous reports [42, 64],
Therefore, ascorbate does not significantly influence the selectivity o f this method. In
addition, ascorbate is unstable, and the dehydroascorbate that forms by oxidation rapidly
decomposes to small sugars, such as trioses. Hence, freshly prepared ascorbate solution
was used to remove the nitrosothiolsfor sample preparation [6 8 ].
We also performed a simple calculation to check whether derivatization would
cause any significant change in the protein mobility. After derivatization, Dylight 488
maleimide was labeled to the nitrosylated proteins, causing only an 800 Da molecular
weight (M W ) shift due to the MW o f the dye. The mobility will not be altered much with
this minimum MW shift when considering the average molecular weights o f proteins
such as BSA (MW = 63 kDa).
In order to distinguish the peaks o f the fluorescence dye itself from those o f the
nitrosylated proteins, the electropherogram o f the Dylight 488 maleimide alone, which
exhibits multiple peaks appearing from 200 s to 400 s, is shown in Figure 3-2 (bottom
Trace 1). M ore than one fluorescence peak was observed since this reagent is an
isomeric mixture.
In vitro nitrosylated BSA was used as a model to test the reactivity o f Dylight 488
maleimide toward SNOs in treated BSA. After the fluorescence switch assay and removal
o f excessive dye, a representative electropherogram o f nitrosylated BSA was shown in
Trace 2 o f Figure 3-2. It depicts that the nitrosylated BSA appears approximately at 690
s. A series o f peaks (200-400 s) occurring before the nitrosylated BSA is attributed to the
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residual Dylight 488 maleimide. However, the control o f ju st the dye (Trace 1 in Figure
3-2) has three well defined peaks in this range, whereas the nitrosylated BSA derivatized
with the dye has a wide range o f peaks in this window. In order to validate that the wide
range o f peaks are indeed from residual dye instead o f SNOs, and further understand why
this visual disparity exists, various controls were used, including untreated BSA, mercury
chloride treated nitrosylated BSA, and the fluorescence switch assay with no protein.
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Figure 3-2: CGE-LIF separation o f nitrosylated BSA labeled with D ylight 488
maleimide. Separation, -570V/cm; hydrodynamic injection, 1lkpa, 4s; sieving matrix,
20mM Tris, 20mM Tricine, 0.5% SDS, 15% dextran (65.5kDa), pH 8 . Top trace and
middle trace are offset on the y-axis for clarity. * — Dylight 488 maleim ide, A—
nitrosylated BSA.

3.3.2

Selectivity and Specificity o f the
Fluorescence Switch Assay
After the derivatization o f untreated BSA with the fluorescence switch assay and

injecting the samples to CE, a significantly smaller peak was detected around 690 s for
SNOs. It was initially expected that no peak for SNOs in the commercial BSA would be
detected. The fluorescence switch S-nitrosylation assay is based on the assumption that
only the S-nitrosylated cysteine residues will be derivatized and fluorescently labeled. I f
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the free thiols o f the cysteine residues have not all been successfully blocked with
MMTS, then the nonblocked cysteines may produce a fluorescence signal in the
electropherogram. To rule out this possibility, M M TS with a high concentration o f 100
mM was used for blocking. Hence, it is believed that the little peak (Trace 3 in Figure 32) was from the SNOs in the commercial BSA, which were previously indicated in other
studies [69, 70].
The primary structure o f BSA has 35 cysteines. Among them, 34 cysteine
residues form disulphide bridges and only one ‘free’ cysteine residue, Cys34 exists [71].
Consistently, the thiol group in native untreated BSA measured by Ellm an’s assay
showed average values o f 0.55 free -SH per mol o f BSA instead o f one -S H group as
expected [70]. This suggested that commercially available BSA is already oxidized at
residue Cys34 [69, 70]. They could form a disulfide bond with several com pounds like
cysteine or glutathione, or undergo nitrosylation o f Cys34 by nitric oxide [72]. Hence,
this significantly smaller peak compared with the one from nitrosylated BSA indicates a
small fraction o f SNO in commercial BSA.
The selectivity o f labeling nitrosothiols using Dylight 488 maleimide was also
studied by incubating nitrosylated BSA with mercuric chloride before the fluorescence
switch procedure. Mercuric chloride (H gCh) can break the S-NO bond, and the newly
formed nitrosonium ion (NO+) can undergo rapid hydration to produce N O 2 ' at neutral
pH [10]. So it was reasonable to see the decreased intensity o f the SNOs signal for the
HgCh treated nitrosylated BSA. In fact, no obvious peak was observed in Trace 4 in
Figure 3-2, confirming the selective Dylight 488 maleimide labeling o f nitrosylated BSA
after derivatization.
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Additionally, the fluorescence switch assay was conducted using a sample
without proteins. N o peaks at 690 s in the protein migration time window were observed,
while the same wide peaks existed ranging from 200 to 400s (shown in Trace 5 o f Figure
3-2). Altogether, these studies further validate that these wide peaks were neither protein
nor SNOs based. Currently it is speculated that this wide range o f peaks preceding the
protein peak might be due to hydrolysis o f Dylight 488 maleimide.
3.3.3

Calibration o f CGE-LIF M ethod with
Nitrosothiol BSA Standard
BSA subjected to RSNO was used as a test model to optimize the derivatization

and labeling procedures and to characterize the response o f the LIF detector. The
standard curve was made by a series o f dilutions o f nitrosylated BSA using CGE-LIF
(Figure 3-3). The NO donor, GSNO, created 76 pmol nitrosothiol/mg o f BSA determined
by Saville assay. This result is in close agreement with the published data [73].
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F igure 3-3: Electropherograms o f a series o f dilution (1-, 2-, 4-, 10-fold) o f
nitrosylated BSA labeled with Dylight 488 maleimide. Other conditions are the same
as in Figure 3-2. *— Dylight 488 maleimide, A— nitrosylated BSA.
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Four dilutions o f Dylight 488 labeling nitrosylated BSA were run in CGE-LIF in
triplicate. The injection volume is 1.1 nL, which is calculated based on the radius (25.1
//m ) and length (31 cm) o f capillary, viscosity o f sample (0 . 0 2 kg/m-sec), injection
pressure (11 kpa) and time (4 s). The calibration curve was made by the fluorescence
peak area (y) o f nitrosothiols on BSA and the corresponding moles o f nitrosothiol (x),
given by the following equation:
y = (1 ± 0.13) xlO l9x - (4.58 ±15.53); R 2 = 0.97.

Eq. 3-1

In the above calibration curve generated from nitrosothiol BSA standard, the
slope has 13% error; and the error in the intercept is not significant for quantifying
nitrosothiols amount because the slope is to the nineteenth power. The Saville assay can
detect 500 nM o f nitrosothiol proteins. So far, the lowest reported lim it o f nitrosothiol
detection based on DAF fluorescence assay was 5 nM [21], The limit o f detection (LOD)
in this CGE-LIF method determined by the above equationF was 1.3 pM , which is the
lowest LOD reported to date. Speculatively, it is proposed that the dynamic range can
reach 4.2 pM (limit o f quantification) at the lowest limit. Theoretically, the upper lim it o f
range occurs when signals are sufficient enough to saturate detectors. However,
biological samples do not typically have high levels o f SNO, so this value is ignored.
3.3.4

M onitoring Nitrosylation in
MO-mediated Cells
The direct application o f this CGE-LIF method in biological systems was

demonstrated in the nitrosylation profiling o f MQ-treated HT-29 cells. After extracting
the proteins from the MQ-treated HT-29 cells, the proteins were treated with fluorescence
switch assay prior to labeling with Dylight 488 maleimide. Figure 3-4 shows the
electropherograms resulting from the hydrodynamic injection o f Dylight 488 maleimide
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labeled proteins o f MQ-treated HT-29 cells (upper trace) and untreated samples (bottom
trace). The labeled HT-29 cell proteins were detected between 420 and 880s, which are
denoted by “a” and “b” in Figure 3-4. This indicates a wide M W range o f proteins that
are susceptible to nitrosylation.
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Figure 3-4: Electropherograms o f extracted proteins from HT29 cells after
fluorescence switch assay. Top and bottom traces represent MQ treated and untreated,
respectively. All the experimental conditions are the same as in Figure3-2. Top trace is
offset in the y-axis for the clarity. *— Dylight 488 maleimide; migration window
between a and b indicated nitrosylated proteins.

Based on the previous equation, the total nitrosothiol content detected in each
electropherogram for M Q-treated and untreated HT-29 cells (cf. Figure 3-4) were 65.5 ±
0.9 amol and 45.9 ± 2.4 amol (average ± SD; three injections), respectively. Based on the
BCA analysis o f the same preparation (4.04 mg protein/mL for the M Q treated HT29
cells and 3.92 mg protein/mL for the untreated one) and a 1.1 nL injection (11 kPa, 4 s)
per electropherogram, the total protein content was 4.44 ng for the MQ treated HT 29
cells and 4.3 lng for the untreated one. Therefore, the untreated cells contained a low
level o f SNO (10.4±0.5 pmolnitrosothiol/mg protein), and treatment with MQ resulted in
a 1.5-fold increase in SNO content 14.8±0.2 pmolnitrosothiol/mg protein). These results
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are consistent with other reported values (from

100

nmol/mg o f protein to

10

pmol/mg o f

protein) for nitrosothiols in various biological tissues [74-76].
3.3.5

Monitoring Nitrosylation in AD Tg
Mice Brain
Another direct biological application o f this CGE-LIF method was demonstrated

in analyzing nitrosylation in very small amounts o f the cerebrum o f five-m onth-old AD
transgenic B 6 Cg-Tg mice. Figure 3-5 shows eletropherograms o f five-month-old B 6 CgTg mice cerebrum labeled with D ylight 488 maleimide. The fluorescence o f Dylight 488
maleimide-labeled SNOs was detected between 500 and 1248s (indicated by “a” and “b”,
respectively) in both Tg and WT cerebrum. The region between a and b were included in
the calculation o f the total area for nitrosothiol determination.
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Figure 3-5: Electropherograms o f cerebrum from five-month-old transgenic (upper
trace) and wild type (bottom trace) mice brain tissue. All the experimental conditions
are the same as in Figure 3-2. Top trace is offset in the y-axis for the clarity. *—
Dylight 488 maleimide; migration window between a and b indicated nitrosylated
proteins.

Based on the Eq. 3-1, the total nitrosothiol content detected in each
electropherogram for Tg and WT (c f Figure 3-5) was 71.2±2 and 62.3±1.7 amol (average
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± SD; three injections), respectively. The total injected protein content was 4.58 ng and
5.38 ng for Tg and WT, respectively based on injected volume o f 1.1 nL. Thus, the
concentration o f nitrosylated protein in the five-month-old transgenic B 6 Cg-Tg mice was
15.5 ± 0.4 (average±SD; three injections) pmol/mg, while W T cerebrum was 11.7 ±0.3
(average ± SD; three injections) pmol/mg. This preliminary result o f ju st one animal pair
indicates a small difference in brain SNOs expression at five months old, a time stage
right before the amyloid plaque onset in this AD B 6 Cg mice model. Although a
conclusive assessment o f the S-nitrosothiols abundance in this Tg mice cannot be made
based on this initial application, we have demonstrated the capability o f this CGE-LIF
method for monitoring nitrosylation electrophoretic profiles in the AD Tg mouse brain.
This assay will be valuable in further studies for (i) m onitoring 11-month-old AD Tg
mouse brain tissue and WT control; (ii) characterizing SNO MW profiling in various
brain tissues and other biological tissues, such as blood plasma; and (iii) monitoring
longitudinal SNO changes in AD progression.
This newly developed CE-LIF method monitoring nitrosylated proteins in
analysis o f biological samples has several advantages, such as its low LOD, fast analysis
time, high accuracy, and potential for pattern classification. Currently, many assay
techniques for measuring biological SNOs are used near the limit o f detection [18], The
currently developed method allowed only nanogram amount o f protein and it reached the
limit o f SNO detection o f 1.3 pM, which is 103 fold less than the conventional Saville
assay. This CGE-LIF adds great advantages for detecting low abundance o f nitrosothiols
in complex biological samples.

33

Additionally, the results from biological samples indicate a wide M W range o f
proteins that are susceptible to nitrosylation. Although individual protein types were not
fully resolved by CGE, a profile o f nitrosylated proteins was obtained in under 15
minutes, much faster than SDS-PAGE requiring six hours o f analysis. This short analysis
time makes this method potentially useful as a prescreening tool in proteomics studies
aimed at discovering proteins susceptible to nitrosylation.
Also, because CGE can separate samples by size, it can distinguish the interfering
residual fluorescent dye from the SNOs peaks. This further eliminates the false positive
signals from excessive dye and enhances accuracy compared with other
spectrofluorometric assays.
CE-LIF also helps to obtain a molecular weight distribution profile o f nitrosylated
proteins. In future studies based on the data points from electropherograms, this w ork can
potentially be used to investigate genotype-related and age-dependent changes in protein
nitrosothiols in mice AD brain using chemometric techniques such as principal
component analysis [55].
3.3.6

Detection o f S-nitrosvlated Proteins
in HT-29 Cells
To prove the selectivity o f CGE-LIF method, the desired peaks in the

electropherograms were also confirmed. S-nitrosylated proteins in HT-29 cells were
detected and identified using the biotin-switch assay developed by Jaffrey et ah, which is
based on the labeling o f S-nitrosylated cysteine on targeted proteins with a biotin moiety
[25]. This method contains three essential steps: blocking the free thiols with a thiolspecific methylthiolating reagent (MMTS), reducing the S-nitrosothiols to free thiols
specifically by ascorbate, and labeling the thiols from the previous step with biotin-
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HPDP. Detection o f biotinylated proteins was performed by liquid chromatography and
electrospray ionization tandem mass spectrometry (LC-ESI M S/M S) analysis after a
series o f purification steps. The result from H T-29 cells (Figure 3-2) indicates a wide
molecular weight (M w) range o f protein peaks (from 420 s to 880 s) that are susceptible
to nitrosylation. Although the individual protein peaks were not fully resolved by the
CGE-LIF method, the nitrosylated proteins from the wide M w range o f peaks were
identified by the LC-electrospray ionization (ESI) MS/MS. The data in Table 3-1 shows
24 nitrosylated proteins were identified in HT-29 cells, and the wide Mw range o f the
identified proteins was from 11 kDa to 300 kDa. These proteins include cell membrane
proteins, nucleus proteins, cytoskeleton proteins, cell cycle proteins, signaling proteins,
redox-related proteins, and folding-related proteins. The representative MS/MS peptide
spectra o f nucleolin and isoform 1 o f vinculin are shown in Figure 3-6.

Table 3-1: S-nitrosylated proteins from MQ treated HT-29 cells identified by (ESI)
MS/MS.
Num ber
Identified protein
Accession num ber M olecular weight
____________________ (HT-29 cell)__________________ (IPI)________ (kDa)____________
Redox-related proteins
1

Protein disulfide-isomerase
A4
Transcription factors
2

Isoform B o f GC-rich
sequence DNA-binding factor

IPI00009904.1

72.9

IPI00069267.2

93.1

1

Nucleus protein
3

Histone H I.2

IPI00217465.5

21.4

4

Histone H4

IPI00453473.6

11.4
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Table 3-1 (continued): S-nitrosylated proteins from M Q treated HT-29 cells identified
by (ESI) MS/MS.
5

Histone H2B type 2-E

IPI00003935.6

13.9

6

Lamin A/C

IP I00514204.3

53.2

7

Nucleolin

IPI00604620.3

76.6

8

Isoform 5 o f Treacle protein

IPI00555853.2

96.7

9

Putative uncharacterized
protein DK FZp779G l 18
(Fragment)

IPI00744556.1

14.5

HSPA5 protein

IPI00003362.2

72.4

IPI00043863.2

8 8 .2

IPI00217113.1

157.7

IPI00796316.4

77.7

IPI00966664.1

1 1 .0

Chaperones
10

Cytoskeleton proteins
11

Isoform 3 o f Microtubuleassociated protein 4
12 Isoform 3 o f CAP-Gly
domain-containing linker
protein 1
13 cDNA FLJ53327, highly
similar to Gelsolin
14 Putative uncharacterized
protein TPM3
Receptors and membrane proteins
15

Isoform 1 ofV inculin

IPI00291175.7

116.6

16

p i 80/ribosome receptor

IPI00856098.1

165.6

Signaling proteins
17

FYN-binding protein

IPI00446986.3

85.3

18

cDNA: FLJ22670 fis, clone
HSI08684
Isoform Short o f
Adenomatous polyposis coli
protein

IPI00018624.3

15.6

IPI00215877.2

300.1

19

36

Table 3-1 (continued): S-nitrosylated proteins from MQ treated HT-29 cells identified
by (ESI) MS/MS.
Protein synthesis factors
20

EEF1A protein (Fragment)

IPI00382804.1

24.1

Invadolysin

IPI00925115.1

68.2

Cell cycle
21

Protein folding
22

Putative uncharacterized
protein FRMD4B

IPI00946418.1

18.7

23

cDNA FLJ53328, highly
similar to M ethylcrotonoylCoA carboxylase subunit
alpha, mitochondrial
cDNA FLJ51535, highly
similar to
Phosphatidylethanolaminebinding protein 1

IPI00789136.2

52.6

IPI00908746.1

17.3

Others

24
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Figure 3-6: MS/MS peptide spectra o f nucleolin (a and b) and isoform 1 o f vinculin (c
and d).
3.3.7

Repeatability and Precision o f CGE-LIF
The repeatability and precision o f the method was determined by performing

injection repeatability and analysis repeatability in replicate (n—5) injection o f the BSA
standard solutions [77]. Injection repeatability was m easured by performing five replicate
injections o f the BSA standard solutions; analysis repeatability was measured by the
injection o f five different samples prepared by the same sample preparation procedure.
The relative standard deviation (RSD) values for migration time and peak area were 0.3
and 4.2 %, respectively. The RSD values for migration tim e and peak area were 0.4 and
1.4 % in the measurement o f analysis repeatability. From the data, it was observed that
the RSD value o f the peak area in analysis repeatability was a little higher than in the
injection repeatability. This may suggest the importance o f the freshly prepared samples.
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In injection repeatability, the SNOs in samples may decrease with each replicate.
However, the analysis repeatability has the advantage o f freshly prepared samples, thus
leading to lower RSD value.
The precision o f the method was determined by perform ing intra-day and day-today assays by replicate (n=5) injection o f the mixed standard solution. Intra-day assay
precision was done by measuring the BSA standard solutions during the same day,
whereas day-to-day precision m easured the same BSA standard solutions for five
consecutive days. For intra-day precision, the RSD values o f migration time and peak
area was 0.2 and 3.2 %, respectively; for day-to-day precision, the corresponding values
were 0.2 and 2.7 %. The data suggests similar precision for intra-day and day-to-day
assays. These results demonstrate that CGE-LIF method can be regarded as repeatable
and precise since the RSD values for the migration time and peak areas are all < 5.0%.

3.4

Conclusions

A method for detection and quantification o f nitrosylated proteins using
fluorescence switch assay coupled with CGE-LIF was developed. This m ethod can detect
1.3 pM concentration o f nitrosylated proteins in nanogram amounts o f proteins, which is
the lowest LOD reported to date. This method also demonstrated its capability in
monitoring nitrosylation in both cell culture and tissue systems. Due to the small sample
need, it is envisioned that the method can be extended to investigate protein nitrosylation
profiles in minuscule brain tissues and/or blood plasm a in the disease progression o f AD
transgenic mouse models.

CHAPTER 4

TWO-DIMENSIONAL NITROSYLATED PROTEIN
FINGERPRINTING BY USING POLY
(METHYLMETHACRYLATE)
MICROCHIPS

4.1

Introduction

Protein S-nitrosylation, the covalent modification o f a cysteine sulfhydryl group
by nitric oxide (NO), plays a critical role in post-translational modification (PTM ) that
regulates a large variety o f cellular functions and signalling events [44], The increasing
evidence shows this redox-based modification is a biomarker in many diseases, including
Alzheimer’s disease (AD), Parkinson’s disease (PD), H untington’s disease, diabetes, and
stroke [1, 45-48]. AD is the most common type o f dementia in the elderly population
[45]. Previously, an ultrasensitive method o f coupling fluorescence switch assay with
CGE-LIF system to detect the S-nitrosothiols in biological sample was developed [78].
The fluorescence switch assay procedure consists o f the derivatization o f nitrosothiols
into free sulfhydryl groups followed by specific labelling o f sulfhydryl-containing
proteins with Dylight 488 maleimide (Ex/Em - 493/528 nm). This procedure proved to
be adequate for analyzing nanogram protein samples with picom olar levels o f
nitrosothiols in less than 15 minutes in a capillary format. However, this one dimensional
(ID ) gel electrophoresis was unable to separate all individual nitrosylated protein
components in the complex biological samples with high dynamic range due to its
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relatively poor peak capacities [79]. For this reason, the development o f multi
dimensional techniques is necessary for analyzing complex biological samples.
2D separation techniques have been developed for the analysis o f complex
biological samples [80]. Conventional 2D-gel electrophoresis is one o f the most widely
used methods, which is a combination o f isoelectric focusing (IEF) in the 1st dimension
followed by sodium dodecyl sulphate polyacrylam ide gel electrophoresis (SDS-PAGE) in
the 2nd dimension[34]. This technique has the capability o f resolving 5000 proteins [34,
35], and 10,000 proteins can be resolved by large sized 2D-gels [36], However, this
method has some major issues, such as poor reproductibility, time consumption and
labour-intensive experimental procedures.
M icrochips offer various advantages, such as short analysis times, minimal
sample volumes, reduced dead volumes, high peak capacities and easy coupling o f
multiple separation channels [37], Although the common modes o f protein CE separation
have been adapted to the chip format, the multidimensional approaches are still in
progress. If the separation mechanisms are orthogonal, the peak capacity o f a
multidimensional separation is the product o f the individual peak capacities obtained
from each individual separation [81].
Several groups have explored the application o f electrokinetically driven
separation techniques on different 2D m icrochip systems to illustrate multidimensional
peptide and protein separations [82], Li et al. described a 2D-CE plastic microfluidic
network system for IEF and SDS-PAGE analysis [83]. Yang and co-workers reported a
2D IEF/PAGE separation o f E. coli proteins using a poly (methylmethacrylate) (PM M A)
microchip [84]. However, IEF as the 1st dimension in the microchip separation contains
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two drawbacks. First, IEF increases the overall development time o f the 2D separation,
resulting from an equilibration step prior to the focusing step [84], Second, IEF is not
compatible with highly hydrophobic proteins since they are not compatible with the
aqueous IEF buffers typically used [39],
To avoid the drawbacks o f IEF, m icrom icellar electrokinetic chromatography (//M EKC) [85, 86] and open-channel electrochromatography (OCEC) [87] have been
coupled with capillary electrophoresis on a m icrofluidic device for the 2D separation o f
trypsin-digested peptides. Soper and co-workers employed SDS micro-capillary gel
electrophoresis (SDS //-CGE) and //-MEKC electrophoresis in the 1st and 2nd dimensions,
respectively, reporting to sort ten model proteins [38] and serum proteins [39] using a
PM M A microchip. The 2D electrophoresis system could generate a peak capacity o f
-2 ,6 0 0 in less than 30 minutes for proteins isolated from fetal calf serum (FCS). The
same group also combined the SDS //-CGE with micro-emulsion electrokinetic
chromatography (//-MEEKC) and reported that //-M EEKC in the 2nd dim ension was
found to produce higher peak capacities (481 ± 18) compared to //-MEKC (332 ± 17)
[40].
However, many o f the multi-dimensional micro-electrophoresis techniques
primarily demonstrated their proof-of-concept separation using several model proteins,
with only few applied to the true biological samples. To date, no known group has
investigated profiling o f oxidatively stress-induced biomarkers for disease phenotypes
using the 2D //-CE. This application could help in fingerprinting a panel o f
electrophoretically separated biomarkers associated with diseases and further act as a tool
to distinguish various phenotypes. To address this issue, a 2D micro-electrophoresis
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method for the separation o f complex protein samples and detection o f nitrosylated
protein biomarkers using a PMMA microchip has been developed. The 1st dimensional
separation contained SDS //-CGE, which separated proteins based on m olecular weight.
The 2nd dimension consisted o f a fast p-M EEKC separation, which sorted proteins based
on the difference in analytes retention between an aqueous phase and charged oil
droplets. Effluents from the SDS p-CGE dimension were sequentially transferred onto
the MEEKC dimension using a pulse sample transfer technique. Laser-induced
fluorescence (LIF) was used at M EEKC channel for detecting the fluorophore-labelled
nitrosylated proteins. This work presents the use o f the discussed 2D //-CE system to
characterize the nitrosylated protein expression in both native and oxidant MQ treated
HT-29 cells. The 2D electrophoretic analysis o f nitrosylated protein in 11 -month-old AD
transgenic mice brain tissues and their age-matched wild-type controls are also reported.
For future study, nitrosylated proteins in five-month-old AD transgenic mice brain tissues
will be compared to their age-matched wild-type controls.

4.2
4.2.1

M aterial and Methods

Materials and Reagents
Methyl hydroxyethyl cellulose (MHEC), IX PBS (pH 7.2), tris (hydroxymethyl)-

aminomethane, heptanes (>99%), 1-butanol (>99%), ovalbumin, avidin, trypsin inhibitor,
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were all purchased from Sigma.
The MEEKC buffer contained 12 mM Tris-HCl,

8

mM heptanes, 90 mM 1-butanol, 0.5%

SDS and also 0.05% MHEC at pH 8.5. Prior to rinsing the microfluidic devices, all the
buffer solutions were filtered using a 0.2 //m Acrodisc syringe filter (Pall Corp., East
Hills, NY). Other chemicals used in this chapter were described in Section 3.2.1.
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4.2.2

M icrochip Fabrication
PM M A was used as the substrate for micro-electrophoresis devices because o f its

high thermal conductivity, separation efficiency, good migration time reproducibility,
low cost and ease o f fabrication [8 8 , 89]. The microfluidic chip layout is shown in Figure
4-1. Six fluid reservoirs contained sample (A), sample waste (B), buffer 1 (C), buffer
waste 1 (D), buffer 2 (E), and buffer waste 2 (F). H igh voltages were applied to these
reservoirs using an independently controlled, programmable six-electrode pow er supply.
The power supply was controlled by a computer w ith an I/O board (PCI 1200, National
Instruments, Austin, TX) and an in-house-written LabV IEW 6.1 (National Instruments)
program.

Figure 4-1: Topography o f the micro-electrophoresis chip used for the 2D separations.

Channel lengths were ten mm for injection channel, 20 mm for both the SDS //CGE (C-D channel) and //-MEEKC separation (E-F channel) dimensions. All channels
were 15 //m wide and 30 //m deep. Microfluidic chips were designed using A utoCAD
2010 (Autodesk Inc., San Rafael, CA) and fabricated by following the procedure
described previously [39], Briefly, microfluidic features were fabricated into a brass plate
using a micromilling machine (Kern M icro und Feinwerktechnik GembH and Co., KG,
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M umau, Germany). Then this brass plate was used to produce PMMA (MSC, M elville,
N Y ) chips by hot embossing. A PHI Precision Press model TS-21-H-C (4A)-5 (City o f
Industry, CA, USA) was used, and the molding tools were heated to 160 °C for pressing
the brass plate into the PMMA plate with a pressure o f 1100 psi for -4 1 0 s [89].
Following the embossing, the PMMA substrate was cooled to room temperature and
removed from the molding die. The embossed PMMA substrate was cleaned with 50%
isopropanol in ultrapure water. Finally, a PM M A cover plate (0.25 mm) was bonded via
thermal fusion to the substrate by heating in a temperature programmable furnace to

110

°C for 20 minutes.
4.2.3

LIF Detection and Data Acquisition
Fluorescence detection was set up using an in-house constructed laser induced

fluorescence (LIF) system (Figure 4-2). A schematic diagram o f this detection system has
been described previously [39]. A 500 mW, 488 nm blue laser (Coherent, Chicago, IL)
was used as the excitation source. A density filter collimated the light from the laser to
the 500 nm long pass (LP) dichroic filter. A 4 0 x, NA=0.65 microscopic objective was
employed to focus the excitation beam onto the microchip at point di in MEEKC channel
(see Figure 4-1). The emission o f the sample passed through the 500 nm LP dichroic
m irror to the second 540 nm LP dichroic mirror. The resulting Dylight 488 emission was
then spatially filtered through a

1

mm pinhole and spectrally filtered using a band-pass

filter (520DF5). To reduce background noise, the whole detection setup was contained in
a black box, and special care was taken to reduce the scattered light w ithin the box.
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Figure 4-2: Diagram (top) and picture (bottom) o f the in-house constructed LIF
system.

The data acquisition and control o f the high voltage power supplies were
created by LabVIEW 6.1 software (National Instruments, Austin, TX, USA). The
resulting signal was digitized by an I/O board (PCI-6602, National Instruments). The
raw data collected from LabVIEW

6

.1 was further analyzed by Igor Pro software

(Wavemetrics, Lake Oswego, OR). A custom Igor procedure was created to generate
the 3D map analysis o f the fluorescence peaks.
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4.2.4

Standard Proteins Fluorescence Labelling
A mixture o f five proteins (bovine serum albumin, ovalbumin, avidin, trypsin

inhibitor, glyceraldehyde 3-phosphate dehydrogenase) was prepared at 5 mg/mL
concentration (in deionized water solution) for each protein without further purification.
Proteins were fluorescent-tagged according to m anufacturer’s guidelines o f Dylight 488
maleimide (Pierce). Dylight 488 m aleimide was used to react with thiols o f cysteine
residues in these model proteins, creating a highly fluorescent product. Briefly, the
proteins’ disulphide bond was reduced to generate more thiol groups on cysteine residues
by adding tris-(2-carboxyethyl) phosphine (TCEP) into the sample solution. Cysteines
then reacted with the Dylight 488 maleimide in an approximate 1:10 molar ratio for at
least two hours at room temperature. To remove the unreacted Dylight 488 maleimide
dye from the sample, the sample was centrifuged six times at 4500xg (Centrifuge 5804 R,
Eppendorf) for 20 m inutes each using the Amicon filter with 3000 M W cut-off [25, 60].
The washing solvent was the //-CE separation buffer. After removal o f excessive dye, 5
//L o f 20% SDS in separation buffer was added to a final volume around 100 //L to
denature proteins. The final solution was centrifuged for five minutes at 6000 rpm
(Centrifuge 5804 R, Eppendorf) to remove any particles.
4.2.5

Isolation o f Brain Tissue from AD
Transgenic Mice Model
Double hemizygous AD-Tg mice (B 6 .Cg-Tg, stock no. 005864, Jackson

Laboratory, Bar Harbor, ME) with over expression o f mutated fonns o f Swedish amyloid
precursor (ApPPswe), presenilin (PSEN ldE 9) and their wild type littermate were used.
Since the AD-Tg mice start to develop amyloid plaques at five to six months old, a pair
o f 11-month old transgenic mice (B 6 Cg-Tg) and their age-matched wild type (WT)
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controls were used to study the expression o f nitrosylation long after the pathological
plaque manifestation. M ouse gender was not taken into consideration in this research.
The detailed protocol is the same as Section 3.2.6.
4.2.6

Fluorescence Switch Assay
To detect a trace amount o f nitrosylated proteins in biological samples (oxidant

mediated cell culture and AD brain homogenate), targeted nitrosylated proteins were
derivatized
chips.

and fluorescently labelled for their subsequent electrokinetic separation on

The detailed procedure o f fluorescently labeling o f nitrosylated proteins was

described in Section 3.2.7.
The untreated HT-29 cells, 11-month-old Tg B 6 Cg-Tg mice brain tissues and
their age-matched controls followed the same procedure.
4.2.7

#-CE (2D) M icrochip Operation
The procedure for running the 2D micro-electrophoresis separation was as

follows: First, prior to the electrophoretic separation, MHEC was dissolved in PBS (pH
7.2) to a concentration o f 5mg/mL. This solution was injected at reservoir C to flush the
entire microfluidic channel for at least ten minutes. The MHEC was used as a dynamic
coating to control electroosmotic flow (EOF) and reduce protein adsorption to channel
walls. Next, the 1st dimension channel was filled with a CGE sieving matrix. The gel
filling was monitored by bright field microscopy to m ake sure the gel was allowed to fill
the chip exactly at the intersection o f the first and the 2nd dimensions o f the channels. The
2nd dimension was then filled with the MEEKC buffer. Reservoir A was emptied and
subsequently filled with 2 //L fluorescently labelled samples. After the sample was
loaded, a field strength o f 200 V/cm was applied for 30 seconds to m ove the proteins to
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the intersection o f channels A-B and C-D. The electric field was generated by applying a
positive potential at waste reservoir B while grounding the sample reservoir (A). The 2nd
dimension separation was programmed to start after an 80 second electrophoresis run
time in the 1 st dimension.
The SDS u-CGE separation was carried out at 350 V/cm in the 1st dimensional
channel (CD channel) by administering a positive voltage at reservoir D while grounding
reservoir C. Then the pull back voltages (0.07 kV) were applied to both sample and waste
reservoirs (A and B). The 2nd dimensional MEEKC cycle consisted o f a ten second run
operated at field strength o f 400 V/cm (see Table 4-1). This amount o f time was found to
be sufficient to assure that all o f the components injected into the 2 nd dimension reached
the LIF detection zone. After a ten second separation, voltage was turned o ff at F, and the
1 st dimensional

separation was resumed for one second to move more proteins into the

MEEKC channel. This was followed by a ten second separation in the EF channel. The
process was repeated until all proteins were transferred from the 1 st dim ension to the 2 nd
dimension. Pullback voltage was applied throughout entire experiment. The LIF detector
was positioned at point dj (10 mm from the intersection o f channels CD and EF) on EF
channel.
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T able 4-1: Summary o f high-voltage protocol for 2D separations on a PM M A
microchip
Step

Applied voltages (kV) in reservoirs
A

B

C

D

E

F

Injection

Grounded

+0 .2 0

Floating

Floating

Floating

Floating

SDS //-CGE

+0.07

+0.07

Grounded

+0.07

Floating

Floating

Second MEEKC
cycle
1D to 2D sample
transfer

+0.07

+0.07

Floating

Floating

Grounded

+0.08

+0.07

+0.07

Grounded

+0.07

Floating

Floating

4.3
4.3.1

Results and Discussion

Assessment o f Sample Transfer Starting Time
and CGE-to-MEEKC Transfer Cycles
Since the dye in the fluorescence switch assay may not be removed completely

[90], the ID separation and detection o f the fluorophore dye, Dylight 488 m aleimide was
examined first. This study also helped in distinguishing the peaks o f the fluorescence dye
itself from those o f the nitrosylated proteins. Figure 4-3 shows the electropherogram o f
the Dylight 488 maleimide alone, which exhibits multiple peaks. More than one
fluorescence peak is observed since this reagent is an isomeric mixture.
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Figure 4-3: Background signal generated by Dylight 488 maleimide.

The time to start transferring m igrating components from the 1st dimension (CGE)
to the 2nd dimension (MEEKC) in this study depended on the migration time o f the 1st
peak in the SDS /i-CGE dimension. The Dylight 488 maleimide, a small molecule
compared to proteins, showed up as the first peak after 80 s in the 1st dimension (Figure
4-4). Hence we started the l st-to-2'ld dimension transfer at 80 s. To assure all the peaks in
the 1st CGE dimension would be transferred and sampled in the 2nd MEEKC dimension,
the total number o f required cycles was determined according to the transfer time o f one
second and the last band migration tim e determined experimentally in the 1 st dimension.
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Figure 4-4: ID separation (SDS p-CGE) o f dye (Dylight 488 maleimide) using the
PMMA microchip.

4.3.2

//-CGE (ID ) and //-MEEKC (ID ) Separation
o f Standard Proteins
Five model proteins consisting o f bovine serum albumin (BSA) (66,000 Da),

ovalbumin (43,000 Da), avidin (64,000 Da), trypsin-inhibitor (20,000 Da) and
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (36,000 Da) were employed for
demonstration o f 1D separations in //-CGE and 1D MEEKC chip.
CGE mode is perhaps mostly employed in microchips for protein separation.
Because a pullback voltage is applied during ID separation, only the proteins in the
channel intersection are injected. Therefore, a total volume o f 6.75 pL o f solution is
analyzed in this study. Hence, 33.75 pg o f each protein was detected based on the
concentration o f 5 mg/mL for each standard protein. The limit o f detection for this
dimension was estimated as 4.53 attomole when signal-to-noise ratio was set at 3. A
linear plot o f logarithmic molecular mass-log (MW) versus the corresponding migration
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tim es (MT) was constructed for SDS //-CGE separation (Figure 4-5), and an equation
was obtained as follows
lo g ( M W ) = 3 x 1 0~3M T + 3.948.

4.5 -|
4 .8 -

y = 0 .0 0 3 x 4 3 .9 4 8
RJ = 0 .9 9 2

4 .7 -

8
5

4 '6

S

4 -5 -

2

3

-

4 .4 4 .3 4 .2 - 0

r------

f------------ —----- n
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M ig r a tio n t i m e is)

300

Figure 4-5: Plot o f the logarithm o f molecular mass versus corresponding migration
tim es o f the SDS //-CGE separation o f five standard proteins ranging in M W from 206 6 kDa.

The plot shows good linearity (R 2=0.992) across the molecular w eight range
studied (20,000-66,000 Da). The sieving electrophoresis dimension o f the ID separation
provides an estimate o f molecular weight sim ilar to that provided by other sieving
electrophoresis methods, such as conventional CE separation [56],
From the SDS //-CGE separation, the size-based //-CG E separation was unable to
resolve all five standard proteins since BSA and avidin have similar m olecular weight.
Elowever, all five model proteins were successfully resolved in phase retention based
M EEKC separation (Figure 4-6).

53

7 00
/ —-v

D

GAPDll

<

600

1

500

£
a
g

a>

oCA
e
§

Avidin

/fBSA

/ ^O valbum in

4 00
Dye

3 00

E
ITypsin-inhibitor

200

100
0

20

40

60

80

100

Migration Thne (s)

Figure 4-6: MEEKC separation o f five standard proteins.

Peak capacities were then calculated for individual peak profiles from the CGE
and MEEKC separations [8 6 ], A peak capacity o f 48 in the first CGE separation was
estimated by assuming a span o f migration time that peaks appear over an average
separation baseline width o f five seconds. For M EEKC, the model protein produced an
average separation baseline width o f two seconds over a separation window o f 16
seconds, which resulted in a peak capacity o f eight. W ith the orthogonal m icro
electrophoresis chip design o f CGE and MEEKC, the overall peak capacity in the current
protein separation platform was estimated to be around 304 (48 and eight in the 1st and
2 nd dimension,

4.3.3

respectively).

a-CGE/M EEKC Separation (2D) o f
Standard Proteins
A set o f five standard proteins was analyzed with the 2D-//CE system. A set o f

five spots was observed in Figure 4-7. In this study, SDS //-CGE was selected as the 1st
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dimension because o f the rapid separation and easy diffusion o f the protein samples into
the MEEKC channel. To completely transfer the protein plug from the 1st CGE
dimension to the 2nd MEEKC dimension, the electrokinetic-based technique was
employed to inject effluent every one second.
M E E K C m ig ratio n tim e ( s )
0
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frry p s in -in h ib iio ^
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TrypsinJnhibitOf
Ovalbuminl
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Figure 4-7: Landscape image from five standard proteins. (A) Contour image for the
microchip 2D SDS //-CGEx/z-MEEKC separation profile o f five standard proteins. The
density in this plot is proportional to the fluorescence intensity. (B) Corresponding
microchip 2D SDS //-CGEx//-M EEKC separation. The height o f the peak is
proportional to the fluorescence intensity.
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The gel/MEEKC buffer solution interface helped isolate these two separation
media and further provided protein stacking during electrokinetic transfer between the
coupled separation dimensions.
In the future, each protein should be run individually to correspond to the m ixed
sample.
4.3.4

//-CGE (ID ) o f Nitrosylated Proteins
from HT-29 Cells
To demonstrate the detection o f nitrosylated proteins after nitrosothiol

derivatization and fluorescence labelling, the ID //-CGE separation o f proteins from the
human colon epithelial adenocarcinoma cell line HT-29 was first investigated (Figure 48 ).

Approximately, 50 peaks were counted with different levels of resolution and width.

These differences resulted from protein peaks overlapping at a close range o f MW. The
first and last migration components have migration times o f 125 seconds and 450
seconds, respectively. Based on this defined migration w indow and the average
separation baseline width estimated as 5 seconds, a peak capacity o f 65 was generated in
the 1-D //-CGE separation o f nitrosylated proteins in HT-29 cells. The widely used
formula (N=5.545 tR2/wy22) was used to calculate the theoretical number in the 1st
dimensional separation o f nitrosylated proteins isolated from HT-29 cells. The separation
efficiency amounts to up to 2.81 xlO 5 theoretical plates generated from the h alf height
peak width o f 2 s (Wj/2) and retention time o f 450 s

( / r )

[91]. Since the peaks displayed in

Figure 4-8 are too complex, protein purification and pre-separation need further study.
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Figure 4-8: SDS //-CGE analysis (ID separation) o f HT-29 cells using a PM M A
microchip.

4.3.5

a-CGE/a-M EEK C (2D) Nitrosylated
Protein Fingerprint from HT-29 Cells
Figure 4-9 presents the 2D image and the corresponding 3D landscape image o f

nitrosylated proteins from HT-29 cells. Figures 4-9 A and B present the data from HT-29
cells. The z-axis (fluorescence signal) at each point is proportional to the nitrosylation
abundance. The data consists o f some peak clusters around the 320th cycle. These clusters
undoubtedly consist o f a number o f proteins that co-migrate. The signals from these
components are out o f range o f the photomultiplier tube, which demonstrates the
sensitivity o f the instrument. Since most o f the signals were saturated, in the future
samples should be diluted before 2D separation.
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Figure 4-9: Protein landscape image from HT-29 cells. Panel A is the contour image
from 2D separation profile o f nitrosylated protein extracted from HT-29 cells. Panel B
presents the corresponding 3D landscape image for the 2D contour image.
Figures 4-9 C and D present the 3D landscape o f nitrosylated proteins from HT29 cells that were treated with menadione (MQ). M Q is a redox cycling quinine that has
the redox-cycling capability to acrylate cellular nucleophiles, such as DNA and proteins,
in mitochondrion, considered as the main redox site [52-54]. HT-29 cells treated with
MQ demonstrate an altered cellular phenotype with more peaks appearing. Furthermore,
M Q-treated HT-29 cells generated much larger signals than the untreated cells between

the 350th and 440th cycles. Therefore, it is concluded that exposure to M Q caused an
increase in protein nitrosylation damage. However, we can see that even the 2nd
dimensional separation could not resolve the complex protein mixture in the biological
samples with a separation length o f 10 mm. To increase the peak capacity o f this 2D
separation format, the effective separation channel length could be potentially increased
in the future separation [39].
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Figure 4-9 (continued): Protein landscape image from HT-29 cells. Panels C and D
show the corresponding 2D protein nitrosylation separation images from cells that had
been treated with 200 /zM MQ for 30 minutes.
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Additionally, based on the linearity between the logarithm o f m olecular weight
and electrophoretic mobility (Figure 4-5), these nitrosylated HT-29 cell proteins were
estimated to be in the range from 20 kDa to 300 kDa. Since this range is beyond the one
used in the calibration curve, bigger range o f standard proteins will be used to confirm
this result.
Since the average separation baseline width was determined in the ID n~CE to be
around five seconds, the fraction transfer time was intentionally set at one second leading
to five times o f the second MEEKC separation upon transfer for each peak. This frequent
sampling actually helped eliminate band aliasing artifacts and further improve 2D
profiling accuracy [87, 92].
In order to completely sample all components migrating from the 1st dim ension to
the 2nd dimension, at least a total o f 450 cycles were required with ten seconds separation
in each MEEKC run after one second per transfer. W hen considering the 80 seconds run
time in the 1st CGE dimension, the total development time for the full 2D separation was
around 84 minutes.
4.3.6

Nitrosylated Protein Fingerprint f2Df
from 11-month-old AD M ice Brain
As a second example, Figure 4-10 presents 2D experiments for the protein

nitrosylation fingerprinting from 11-month-old transgenic mice (B 6 Cg-Tg) and their agematched wild type (WT) controls.
Carrying both APP and exon 9 deletion o f the PSEN1 gene, the B 6 C g-Tg mouse
is a valuable model to study the pathological alterations in AD.
A 2D separation o f the nitrosylated proteins in AD transgenic mice (Figure 4-10 A and
B) produced higher peak signals when compared to the wild type controls (Figures 4-10
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C and D) around 165th and 190th cycles. The total 2D separation with LIF detection was
completed in 36 minutes.
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Figure 4-10: 2D separation landscape images o f the nitrosylated proteins from AD
transgenic mice and age matched wild type control. Panels A and B were generated
from 11-month-old AD transgenic mouse brain tissues.
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Figure 4-10 (continued): 2D separation landscape images o f the nitrosylated
proteins from AD transgenic mice and age matched wild type control. Panels C and
D were generated from age related wild type control.
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Additionally, these AD brain proteins, which are most susceptible to oxidative
damage, particularly nitrosylation, were estimated to have a MW between 35 kDa and 65
kDa.
While 2D separation occurs, ID is placed in a standing state. It is not known what
effect a long standing state has on the pre-separated protein bands. However, results
indicate a clear separation o f these proteins in the 2D. Therefore, it is concluded that the
separation efficiency in the 2 nd dimension is great enough to overcome any possible
protein diffusion.

4.4

C onclusions

A complex sub-population o f proteome, nitrosylated proteins was studied,
profiling it using a 2D //-CGE/MEEKC polym er microchip and monitoring its expression
using a LIF detector. The 2D //-CE device achieved high peak capacity, which allows the
separation o f a panel o f nitrosylated proteins. In addition, the ultrasensitive assay o f
nitrosothiol derivatization and labelling allowed monitoring these biomarkers even at a
low abundance level. First, in-vitro nitrosylated proteins were used, including BSA,
avidin, avabumin, GAPDH, trypsin inhibitor, ranging in size from 20 to
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kDa, as the

model to test the performance o f the 2D microchip separation and fluorescence detection.
All o f the five standard nitrosylated proteins were detected using LIF with
excitation/emission at 493/518 nm. Additionally, high peak capacity 2D maps o f complex
nitrosylated protein mixtures were generated from MQ-treated HT-29 cells and 11month-old AD transgenic mouse brain. Finally, the rapid profiling o f oxidative stressrelated protein biomarkers was demonstrated in a complex biological mixture using 2D
micro-electrophoresis. Altogether, oxidative-stress induced biomarker profiling was
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generated. This application could further serve as fingerprints to determine AD disease
phenotypes from biological samples.

CHAPTER 5

IDENTIFICATION OF S-NITROSYLATED PROTEINS AFTER
EXPOSURE OF HUMAN COLON ADENOCARCINOMA
CELLS TO MENADIONE

5.1

Introduction

Protein S-nitrosylation, the covalent m odification o f a cysteine sulfhydryl group
with nitric oxide (NO), plays an essential role in posttranslational m odification (PTM)
that regulates a large variety o f cellular functions and signaling events [44], M ost
organisims are exposed to oxygen specials that may influence the structural configuration
and integrity o f proteins and modulate their function and eventually influence cell
survival. The nitrosylation state changes with oxidative damage and is involved in variety
o f cancers and neurodegeneration diseases [1, 45-48].
Due to the importance o f protein S-nitrosylation, several methods have been
developed to detect nitrosylated proteins in biological samples. These approaches can be
generally divided into two branches: direct methods and indirect methods.
Direct detection o f protein S-nitrosylation includes immunohistochemistry by the
use o f a SNO-specific antibody to detect in vivo protein S-nitrosylation [23],
Conventional methods such as im munoprecipitation, 2D-gel electrophoresis or western
blot are generally not preferable for protein S-nitrosylation because the S-NO bond is
degraded in the SDS-PAGE step [24]. However, the use of biotin switch assay coupled
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with these methods can indirectly detect the changes in protein S-nitrosylation status
under different biological conditions [25],
Currently, a number o f indirect methods are being used for the nitrosothiols
quantitative measurement, which either requires cleavage o f the S-NO bond followed
with NO level measurement or replaces the S-NO w ith another detectable tag. One
widely utilized method is the saville assay [17]. The mechanism o f this method is to
replace NO+ from the thiol group by mercuric chloride in the presence o f sulphamilamide
and then react with N -(l-naphyl)-ethylenediam ine. The reaction product, a colored azo
dye, can be detected by spectrophotometrically at 540nm [20], Biotin switch assay (BSA)
is another widely used method for detecting protein S-nitrosylation [25]. It utilizes a
sulphydryl-specific biotinylating agent to react with free cysteine that is created from
nitrosothiol group (S-NO) to form the biotin tag. Then this method can couple with
immunoblotting, 2D-gel electrophoresis, or fluorescence gel electrophoresis to detect
changes in protein S-nitrosylation status under different biological conditions. Such a
method can effectively determine the total level o f protein S-nitrosylation present in the
biological sample, but they are unable to identify specific S-nitrosylated proteins.
For the identification o f nitrosylated proteins sites in the complex biological
samples, mass spectrometry (M S)-based approaches are required. Due to the lability to
this type o f modification, the direct detection o f MS is still quite problematic. A couple of
indirect methods have been developed for protein identification. The previously widely
used method is the biotinylated proteins purified by avidin affinity chromatography after
BSA and then followed by 2D-gel electrophoresis (2-DE) for MS analysis [5, 7, 26-30].
Few S-nitrosylation proteins have been identified by this approach due to its low
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abundance and to the low recovery o f S-nitrosylated peptides from in-gel digestion. A
new method, SNO Site Identification (SNO), introduced a proteolytic digestion step
before avidin capture [31]. It allows the selective isolation o f peptides that previously
contained S-nitrosylated Cys residues. Sixty eight S-nitrosylated peptides from 56 rat
cerebellar proteins were identified in this study. In this way, only the modified peptides
are enriched and eluted for the following identification by MS: this is a fundamental
improvement because only the localization o f the m odified residue can confer high
confidence as to the results. However, two disadvantages are shown in this method. First,
the identification o f a protein depends on M S/M S-based sequence information inferred
from a single peptide ion. Second, the relative large am ount (lg ) of starting tissue/cells
required. Camerini et al. used an N-term inally modified H is-tag to selectively label the
thiol group (SH) reduced by nitrosothiol group (SNO) instead o f biotin tag [32]. From
this approach, the author got 28 modified Cysteine moieties from 19 proteins. Forrester et
al. recently developed a method named S-nitrosothiol resin-assisted capture (SNO-RAC)
which required fewer steps because it combines the labeling and pull down steps from the
BSA into one step [33]. This approach can detect 44 novel SNO sites in E. coli. The
reporter pointed out that this method appeared to be more sensitive than the BSA for high
mass proteins, and at least as sensitive as the BSA for proteins smaller than 100 kDa.
However, Liu et al. revealed that both the BSA and RAC approaches were not effective
at S-nitrosylation site identification [24], They did not address the issue o f accurate site
localization, especially when more than one cysteine was present in an identified peptide
sequence. They presented a novel and robust method for site-specific high-throughput
identification o f protein S-nitrosylation (SHIPS) in complex protein mixtures. The SHIPS
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approach utilized a cysteinyl affinity resin to pull down ascorbate reduced S-nitrosylated
peptides, rather than S-nitrosylated proteins. Two commonly used alkylation agents,
acrylamide and iodoacetamide, were employed to differentiate free and disulfide-bonded
cysteine form reduced S-nitrosylated cysteine [24], A total o f 162 S-nitrosylation sites
were identified, and an S-nitrosylation m otif was revealed in this study.
Cancer is commonly referred to as a genetic disease. However, the functional
product, the protein, is what determines the signaling events that lead to cancer
progression. A num ber o f alterations can occur at the posttranslational level to affect
function (i.e., phosphorylation, carbonylation, S-nitrosylation). Cancer chemotherapeutic
agents inhibit cancer cell proliferation, but also cause damage to these cells and normal
cells by inducing oxidative stress. Menadione (MQ), a redox cycling quinone used with
cancer chemotherapeutic agents, results in oxidative protein S-nitrosylation damage in
human colon adenocarcinoma cells (HT-29) [78]. MQ has been used in conjunction with
cancer chemotherapeutic agents to treat various cancers [93]. MQ has the redox-cycling
capacity to acrylate cellular nucleophiles such as DNA and proteins, with mitochondrion
considered as the main redox site [52-54, 93]. Proteins in cellular and subcellular
members and in the cytoskeleton may be altered by MQ [93], Thus, MQ is proposed to
initiate a cascade o f ROS formation which leads to cell injury and death (Figure 5-1).
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F ig u r e 5-1: T he potential dam age M Q induced in c e lls.

Oxidative protein nitrosylation damage mediated by menadione (MQ) was
monitored. To extend the capability o f the biotin-switch method, a proteolytic digestion
step before avidin capture was introduced. This changed step provides for the selective
isolation o f peptides that previously contained SNO-Cys residues, rather than intact SNO
proteins in the original biotin-switch method [31]. Then, liquid chromatography tandem
MS (LC-MS/MS) was exploited for high-throughput peptide identification, thereby
describing the set o f SNO-Cys sites on proteins. Among the 20 S-nitrosylated proteins
identified in the M Q-treated HT-29 cells, 17 o f them are novel targets o f S-nitrosylation.
The identification o f these novel S-nitrosylated proteins may benefit the oncology
community in treatment.

5.2
5.2.1

M aterial an d M ethods

Materials and Reagents
Biotin-HPDP and streptavidin-agarose were purchased from Pierce. Acetone was

purchased from VW R International. Other materials and reagents were previously listed
in Section 3.2.1.
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5.2.2

In Vitro Nitrosylation o f BSA and SNO
Quantification by Saville-Griess Assay
An internal control experiment was perform ed to confirm that the same am ount o f

sample and control was added. The procedure was previously described in Section 3.2.3.
5.2.3

Labelling o f S-nitrosylated Proteins
by the Biotin Switch Assay
The biotin switch assay was performed as described by Jaffrey and Snyder [25]

(Figure 5-2). Briefly, the protein concentration was adjusted to 0.8 f^g/juL using HEN
Buffer (250 mM Hepes/NaOH pH 7.7, 1 mM EDTA, 0.1 mM neocuproine) and then
incubated at 50 °C for 30 minutes in Blocking buffer (nine volumes o f HEN buffer, one
volume o f SDS (25% w/v in H 2 0 ) and a final concentration o f 20 mM MMTS) with
frequent vortexing. Acetone precipitation was perform ed to remove MMTS. The protein
pellet was re-suspended in 0.1 mL HENS solution (HEN Buffer in 1% SDS) per mg
protein, followed by incubation with 2 mM biotin-HPDP and 2 mM ascorbate for 1 hour
at 25 °C. Until this point, all operations were carried out in the dark. A fter biotinylation
to label S-nitrosylated proteins, biotin-HPDP was removed by acetone precipitation and
centrifugation, and the pellet was resuspended in 0.5 mL HENS buffer.
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F igure 5-2: Schematic o f the biotin switch assay technique following the track o f
protein S-nitrosylation.
5.2.4

Purification o f S-nitrosylated Proteins
for Proteomics
The biotinylated proteins were incubated with trypsin (1 :1 0 enzym e/ protein

ratio) at 37 °C for overnight. The peptides were recovered and incubated with 50 //L o f
streptavidin-agarose beads per mg o f initial protein for 30 minutes with gentle mixing.
Samples were centrifuged at 5,000 x g for five minutes, and the supernatants were
discarded. The beads were washed five times with ten volumes of 1 M ammonium
bicarbonate, followed by five washes with ten volumes o f deionized water. Between
washes, samples were centrifuged at 1,000 x g for one minute. Elution buffer containing
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70% formic acid (FA) was incubated with the beads for 30 minutes with gentle mixing.
The captured peptides were recovered by centrifuging beads at 5,000 x g for four minutes
and collected the supernatant. To ensure complete removal o f streptavidin-agarose, the
samples were centrifuged again. The supernatant was collected and was further purified
with a mixed-mode cation exchange column prior to liquid chromatography-tandem mass
spectrometry (LC-MS/MS) analysis [6 ].
5.2.5

Analysis by LC-MS/MS
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis was

performed as described in previous report [94, 95]. Briefly, the peptide fragments
extracted from streptavidin were separated and analyzed using a capillary LC system
coupled with a nanospray quadrupole time-of-flight micro m ass spectrometer (Waters
Corp., Milford, MA). The MS was operated in a data-dependent acquisition mode. Then a
full survey MS scan was followed by three MS/MS scans using normalized collision
energy. The instrument was set up in positive ion mode, with an electrospray voltage o f
3.5 kV, sample cone voltage o f 40 V, and extraction cone voltage o f 1.5 V. The peaklist
(pkl) files were generated using ProteinLynx Global Server 2.2.5 (PLGS 2.2.5, Waters
Corp.) Tandem mass spectra were analyzed using the PLGS 2.2.5 (Waters Corp.) and
MASCOT (version 2.2, Matrix Science, Cambridge, MA) software against a Swiss-Prot
database (release 57.3, 468 851 sequences) [95], For both PLGS and M ASCOT, the
database search settings included variable modifications o f biotin-HPDP o f cysteine
residues (+428 atomic mass units); precursor-ion mass tolerance, 200 ppm; fragment-ion
mass tolerance. M Q oxidation o f protein was allowed as a variable modification in the
databank search query in PLGS and MASCOT, and automodification query was selected
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to identify peptides with further post-translational modifications in PLGS. The top
ranking hits (score 8-13 for PLGS and p< 0.05 for M ascot assignment o f identity) were
scrutinized based on molecular weight, pi, and sequence coverage. Spectra were also
examined carefully to verify that the spectra included a good number o f consecutive “y ”
ions with high mass accuracy. If peptides matched to multiple members o f protein family
with similar sequences, the protein identified was the one with the highest num ber o f
matched peptides and score [94],

5.3
5.3.1

Results

Proteomic Analysis o f S-nitrosylated
Proteins in MQ Treated HT-29 Cells
To determine the proteomic profile o f S-nitrosylated proteins in HT-29 cells, the

biotin-switch method was used combined with a proteomic approach. S-nitrosylated
proteins extracted from HT-29 cells undergoing M Q exposure were subjected to the
biotin-switch method, digested overnight, purified by affinity chromatography on a
strepavidin-agarose matrix and then separated by LC-M S/M S. Four biological replicates
were carried out for the data analysis. Twenty proteins were detected and included in the
analysis o f MQ treated HT-29 cells (Table 5-1). Among the 20 proteins, ten o f them are
identified in the untreated HT-29 cells (Table 5-2).The proteins identified were members
o f specific functional families including folding proteins, chaperones, m etabolic proteins,
signaling proteins, cytoskeleton proteins, and membrane proteins. Three o f these,
Elongation factor 2, Elongation factor 1 A -l and L-lactate dehydrogenase B chain, have
been previously reported to be S-nitrosylated in other systems [6 , 28, 29],
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Table 5-1: S-nitrosylated proteins identified by LC-MS/MS in HT-29 cells
preincubated with MQ.
Protein ID
(MQ treated HT29 cells)

Description

RS7JHUMAN

40S ribosomal
protein S7 OS
Homo sapiens
GN RPS7 PE 1
SV 1

HSP77_HUMAN

Putative heat
shock 70 kDa
protein 7 OS
Homo sapiens
GN HSPA7 PE 5
SV 2

3

LDHBHU MAN

L lactate
dehydrogenase B
chain OS Homo
sapiens GN
LDHB PE 1 SV

4*

LDHAJ-IUMAN

5*

GSTOIJHUMAN

6*

PGK1 HUMAN

Number
(NO.)

Accession
NO.

Molecular
Mass
(kDa)

PI

2 2 .1

1 0 .6

P48741

40.2

7.9

P07195

36.6

5.6

P00338

36.7

8.4

P78417

27.5

6 .2

P00558

44.6

8.1

Protein folding
1

Chaperones
2*

Metabolism

2

L lactate
dehydrogenase A
chain OS Homo
sapiens GN
LDHA PE 1 SV
2

Glutathione S
transferase
omega 1 OS
Homo sapiens
GN GSTOl PE 1
SV 2
Phosphoglycerate
kinase 1 OS
Homo sapiens
GN PGK1 PE 1
SV 3
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T ab le 5-1 (continued): S-nitrosylated proteins identified by LC-MS/MS in HT-29 cells
preincubated with MQ.
Translation and posttranslational modification
7

V E2HPV 63

Regulatory
protein E2 OS
Human
papillomavirus
type 63 GN E2
PE 3 SV 1

Q07850

45.4

1 0 .0

Uncharacterized
protein CXorf64
OS Homo
sapiens GN
CXorf64 PE 2
SV 1
Lysine specific
demethylase 7
OS Homo
sapiens GN
JHDM1DPE 1
SV 2
Teashirt homolog
1 OS Homo
sapiens GN
TSHZ1 PE 2
SV2
DNA polymerase
OS Human
adenovirus B
serotype 7 GN
POL PE 3 SV 1
Heterogeneous
nuclear
ribonucleoprotein
U OS Homo
sapiens GN
HNRNPUPE 1
SV 6

B1ATL7

31.9

7.3

Q6ZMT4

106.5

8 .0

Q 6 ZSZ6

117.8

6 .6

P05664

128.6

6.3

Q00839

90.5

5.6

P60866

13.4

10.4

Redox-related proteins
8

CX064_HUMAN

9

KDM7HUMAN

10

TSH1 HUMAN

11

DPOLADE07

12*

HNRPUHUMAN

Translation
13*

RS20HUMAN

40S ribosomal
protein S20 OS
Homo sapiens
GN RPS20 PE 1
SV 1
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Table 5-l(continued): S-nitrosylated proteins identified by LC-M S/M S in HT-29 cells
preincubated with MQ.
Regulation of the colloidal osmotic pressure of blood
14*

ALBU HUMAN

Serum albumin
OS Homo
sapiens GN
S100A10 PE 1
SV 2

P02768

69.3

5.9

Elongation factor
2 OS Homo
sapiens GN
EEF2 PE 1 SV 4
Elongation factor
1 alpha 1 OS
Homo sapiens
GNEEF1A1 PE
1 SV 1
Protein S I00
A10OS Homo
sapiens GN
S100A10 PE 1
SV 2
Serine threonine
protein kinase
MARK2OS
Homo sapiens
GN MARK2 PE
1 SV 2

PI 3639

95.3

6.4

P68104

50.1

9.3

P60903

1 1 .2

7.3

Q7KZI7

87.9

10.1

Actin
cytoplasmic 1 OS
Homo sapiens
GN ACTB PE 1
SV 1

P60709

41.7

5.1

Endothlin
converting
enzyme 1 OS
Homo sapiens
GN ECE 1 PE 1
SV 2

P42892

87.1

5.5

Signaling proteins
15*

EF2HUMAN

16

EF1A1HUMAN

17*

S1OAA H U M AN

18

MARK2HUMAN

Cytoskeleton proteins
19*

ACTBHUMAN

Membrane proteins
20

EC El HUMAN
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Table 5-2: S-nitrosylated proteins identified by LC-M S/M S analysis in untreated HT29 cells.
Protein ID
(Controls)

Description

Accession
NO.

Molecular
Mass
(kDa)

PI

1

S1OAAHUMAN

2P60903

1 1 .2

7.3

2

RS7HUMAN

2P62081

2 2 .1

10 .6

3

EF1 A1_HUMAN

2P68104

50.1

9.3

4

CX064 HUMAN

2B1ATL7

31.9

7.3

5

HSP77HUMAN

2P48741

40.2

7.9

6

RS20HUMAN

2P60866

13.4

10.4

7

LDHBHUMAN

Protein S I00
A10 OS Homo
sapiens GN
S100A10 PE 1
SV 2
40S ribosomal
protein S7 OS
Homo sapiens
GN RPS7 PE 1
SV 1
Elongation
factor 1 alpha 1
OS Homo
sapiens GN
EEF1A1 PE 1
SV 1
Uncharacterized
protein
CXorf64 OS
Homo sapiens
GN CXorf64
PE 2 SV 1
Putative heat
shock 70 kDa
protein 7 OS
Homo sapiens
GN HSPA7 PE
5 SV 2
40S ribosomal
protein S20 OS
Homo sapiens
GN RPS20 PE
1 SV 1
L lactate
dehydrogenase
B chain OS
Homo sapiens
GN LDHB PE
1 SV 2

2P07195

36.6

5.6

Number
(NO.)
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Table 5-2 (continued): S-nitrosylated proteins identified by LC-MS/MS analysis in
untreated HT-29 cells.

5.3.2

8

A L B U _H U M A N

9

M A R K 2H U M A N

10

K D M 7_H U M A N

Serum
album in O S
H om o
sapiens G N
S 1 0 0 A 1 0 PE
1 SV 2
Serine
threonine
protein
kinase
M A R K 2O S
H om o
sapiens G N
M A R K 2 PE
1 SV 2
L ysine
specific
dem ethylase
7 O S H om o
sapiens GN
JH D M 1D PE
1 SV 2

2P02768

69.3

5.9

2Q 7K Z I7

87.9

10.1

2Q 6Z M T 4

106.5

8.0

Identification o f Biotin M odification
Sites in MQ Treated HT-29 Cells
To provide further evidence that the proteins identified by mass fingerprinting

were S-nitrosylated, the biotin modification sites were also identified in HT-29 cells
(Table 5-3). The MS/MS spectra o f identified proteins are shown in Figure 5-3 to Figure
5-12.
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Table 5-3: S-nitrosylated proteins identification o f biotin modification sites in MQ
treated HT-29 cells.

1

Protein ID
(MQ treated HT29 cells)
GSTOl HUMAN

2

EF2HUMAN

3

HNRPUHUMAN

4

LDHAHUMAN

5

ACTBHUMAN

6

PGK1 HUMAN

7

S10AAHUMAN

Number
(NO.)

Description

Accession
NO.

Glutathione S
transferase
omega 1 OS
Homo sapiens
GN GSTOl PE 1
SV 2
Elongation factor
2 OS Homo
sapiens GN
EEF2PE 1 SV 4
Heterogeneous
nuclear
ribonucleoprotein
U OS Homo
sapiens GN
HNRNPUPE 1
SV 6
L lactate
dehydrogenase A
chain OS Homo
sapiens GN
LDHA PE 1 SV

PI

2P78417

Molecular
Mass
(kDa)
27.5

2P13639

95.3

6.4

2Q00839

90.5

5.6

2P00338

36.7

8.4

2P60709

41.7

5.1

2P00558

44.6

8.1

2P60903

11.2

7.3

6 .2

2

Actin
cytoplasmic 1 OS
Homo sapiens
GN ACTB PE 1
SV 1
Phosphoglycerate
kinase 1 OS
Homo sapiens
GN PGK1PE 1
SV 3
Protein SI00
A10OS Homo
sapiens GN
S100A10 PE 1
SV 2
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Table 5-3 (continued): S-nitrosylated proteins identification o f biotin modification sites
in MQ treated HT-29 cells.
8

HSP77JHUMAN

9

RS20HUMAN

10

ALBUHUMAN

Putative heat
shock 70 kDa
protein 7
OSHomo sapiens
GN HSPA7 PE 5
SV 2
40S ribosomal
protein S20 OS
Homo sapiens
GN RJPS20 PE 1
SV 1
Serum albumin
OS Homo
sapiens GN
S100A10PE 1
SV 2

2P48741

40.2

7.9

2P60866

13.4

10.4

2P02768

69.3

5.9
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Figure 5-3: The MS/MS spectra of Protein SI 00 A10.
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Figure 5-4: The MS/MS spectra of Glutathione S transferase.
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Figure 5-6: The MS/MS spectra of Putative heat shock 70 kDa protein 7.
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Figure 5-7: The MS/MS spectra of 40S ribosomal protein S20.
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Figure 5-10: The MS/MS spectra of L lactate dehydrogenase A
chain.
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F ig u r e 5-11: T he M S/M S spectra o f A ctin cytop lasm ic 1.
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F ig u r e 5 -12: M S /M S spectra o f P hosphoglycerate kinase 1.

5.4

Discussion

S-nitrosylation has become recognized as a ubiquitous, specific, and reversible
regulatory reaction comparable to other protein modification. Up to current data, there are
over
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different proteins which have been described as being regulated through the

protein S-nitrosylation in various systems, typically on the basis of in vitro modification
or exogenous sources o f NO [96]. In a previous report, the protein S-nitrosylation in both
MQ treated HT-29 cells and untreated ones is quantified [78]. However, it is poorly
understood how increased nitrosative stress directly affects the cells and their functions.
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Therefore, this research seeks to identify S-nitrosylated proteins in M Q-exposed HT-29
cells compared to the controls.
In the current study, HT-29 cells were exposed to M Q to induce more nitrosylated
proteins modification. Unlike the other studies, there was no component in which cells
were exposed to a source o f exogenous NO. Like the studies previously mentioned, these
results indicate that a large number o f proteins are S-nitrosylated in this setting. Indeed,
three o f the proteins identified as S-nitrosylated in M Q treated HT-29 cells, EF2, EF1 A l,
and L-lactate dehydrogenase B chain, have been reported to be S-nitrosylated in other
systems [6 , 28, 29].
Colon cancer cell lines, HT-29 cells (MQ treatm ent and untreatment), were
analyzed for their nitrosylated content. Both the sample and the control were subjected to
the biotin-switch method for detection o f S-nitrosyalted proteins. It has been suggested
that the biotin-switch method may also detect S-glutothionylated proteins [5]. However,
new evidence indicates that treatments with reduced and oxidized glutathione (GSH,
GSSG) did not show any differences with respect to untreated extracts. Therefore, the
biotin-switch method was considered suitable for studying the protein S-nitrosylation
[97].As was expected, more nitrosylated proteins were identified in MQ treated HT-29
cells, when compared to the control. This increase in the number o f S-nitrosylation
observed in MQ treated HT-29 cells is probably a consequence o f the exposure o f these
cells to MQ. These findings are in agreement with the previous study that MQ was able
to accumulate the overall level o f protein S-nitrosylation in HT-29 cells [78],
Initially, it was expected that differences would be seen in the pattern o f Snitrosylation between M Q treated HT-29 cells and control. However, as shown in Table
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5-1 and 5-2, both the sample and the control have some o f the same pattern o f Snitrosylated proteins.
At least ten proteins that were increased by exposure to MQ in their Snitrosylation status have been identified, as shown in Table 5-1. These increased Snitrosylated proteins can be classed as 1) cytoskeleton proteins (Actin cytoplasmic 1), 2)
metabolic enzymes (L Lactate dehydrogenase A chain, Glutathione S transferase om ega
1, Phosphoglycerate kinase 1), 4) signaling molecules (Elongation factor 2), 5)
transcription factor (Regulatory protein E2, Teashirt homolog 1, DNA polymerase,
Heterogeneous nuclear ribonucleoprotein U) and 6 ) membrane proteins (Endothlin
converting enzyme 1). Many o f these proteins are likely to undergo S-nitrosylation in
other cell types. Because S-nitrosylation has been implicated in the regulation o f
numerous protein activities, the findings that MQ regulates protein S-nitrosylation in HT29 cells could provide a new insight into the mechanisms underlying nitrosylation injury
on the cells. The significance o f these findings and the potential role o f the identified Snitrosylated proteins in apoptosis and cancer are discussed in Section 5.4.1 to 5.4.7.
5.4.1

Signaling Proteins
EF-2, a signaling protein involved in protein synthesis, catalyzes the translocation

o f the peptidyl-tRNA from the A site to the P site o f the ribosome. M ost organisms
encode a single EF2 protein and its activity is regulated by EF-2 kinase resulting in
phosphorylation. S-nitrosylation o f EF-2 might be an alternative mechanism used to
enhance protein synthesis [29].
S 1 0 0 A 1 0 is a member o f the SI 0 0 family o f proteins, which are small acidic
proteins (10-12 kDa) and constitute the largest subfamily o f EF-hand proteins, with at
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least 25 members [98]. A unique feature o f S100A10 is its calcium insensitivity, since it
contains mutations in both o f the calcium-binding sites[99]. The majority o f the S100A10
is found intracellularly in the cytosol or at the inner surface o f the plasm a membrane.
However, S100A10 is also present on the extracellular surface of many cells, where it
binds tissue plasminogen activator (tPA) via its C-terminal lysines [98].
5.4.2

Chaperones
MQ treated HT-29 cells also showed S-nitrosylation o f specific chaperones,

including Hsp70 protein 7 (Hsp77). The heat shock proteins (Hsps) are know n as
molecular chaperones, and help guide protein transport and folding under physiological
conditions. Hsp77 is constitutively present in unstressed organisms, reflecting the
housekeeping function performed under normal circumstances [100]. Although Hsp70
family members have been shown in other proteomics o f nitrosylation papers, the Hsp77
has first been identified in this study. As to the role o f stress-induced Hsps, more work is
needed to understand the exact mechanism by which these proteins provide protection to
the cell, in particular at the tissue level [ 1 0 1 ].
5.4.3

M etabolism
Tumor formation is generally linked to increased activity of glycolytic enzymes.

Inhibition o f glycolysis effectively kills colon cancer cells in a hypoxic environment in
which the cancer cells exhibit high glycolytic activity and decreased sensitivity to
anticancer drugs. Three metabolic enzymes were identified to be S-nitrosylated in MQ
treated HT-29 cells, glutathione S transferase omega 1 (G STO l), phosphoglycerate
kinase 1 (PGK1) and lactate dehydrogenase A chain (LDHA). These three proteins could
be potentially considered as new targets for cancer therapy.
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Glutathione-S-transferases (GSTs) are a family o f Phase II detoxification
enzymes that catalyse the conjugation o f glutathione (GSH) to a wide variety o f
endogenous and exogenous electrophilic compounds [102]. GSTs are divided into two
distinct super-family members: the m embrane-bound microsomal and cytosolic family
members [102], G STOl belongs to the cytosolic family members, which are subject to
significant genetic polymorphisms in human populations. GSTs have emerged as a
promising therapeutic target because specific isozym es are overexpressed in a wide
variety o f tumors [103, 104].
Phosphoglycerate kinase 1 (PGK 1), a secretable glycolytic enzyme, is known to
participate in angiogenesis. A previous study identified PGK1 as a potential biomarker
and/or therapeutic target for pancreatic ductal adenocarcinoma (PDAC) [105], Given that
the ability to respond to changes in oxygen tension is fundamental, in the case o f the
PGK to have been preserved in evolution, the possibility is raised that the oxygenregulated control system may not only act on a wide variety o f genes in mammalian cells
but also have an equivalent in more primitive species. Similarly, LDH, a cellular
metabolic enzyme, also show both structural and functional conservation in evolution
[106].
5.4.4

Post-translational M odification
Specific RNA-binding proteins, such as the hnRNP family, regulate the mRNA

processing, as well as other mRNA-related cell activities [107], About 20 major hnRNP
proteins, from A1 to U, have been described and included in the family by their capacity
to bind to pre-mRNA with no unique structural m o tif or function [108]. HnRNP proteins
are involved in variety o f key cellular functions, such as mRNA splicing, stabilization,
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nucleo-cytoplasmic transport, and transcriptional control [109-113]. Several authors have
reported an association o f hnRNP expression with actively proliferating cells [114-116],
It is still not clear whether the over-expression o f the hnRNP proteins in cancer is a tumor
specific event or rather it is a mere consequence o f the accelerated m RNA metabolism
common to highly proliferative cancer cells [108]. One o f hnRNP family member,
heterogeneous nuclear ribonucleoprotein U (HNRPU), may act as a scaffolding protein
and mediate interactions between target mRNAs and proteins regulating mRNA
expression [117].
5.4.5

Translation
The expression profiles o f the individual ribosomal protein (RP) S20 mRNA

exhibited a constantly down regulation in previous reports [118]. M ost o f the studies o f
the regulation o f RP synthesis have been made in Xenopu. The regulation o f RP synthesis
occurs at four different levels: transcriptional, post-transcriptional, translational and
stability o f the proteins [119, 120]. The majority o f the regulation is at the translational
level, and this is achieved by modulating the fractions o f RP mRNA on polysomes and
stored in RNPs, respectively [118].
5.4.6

Regulation o f the Colloidal Osmotic
Pressure o f Blood
Human serum albumin (ALBU) is the most abundant protein in the circulatory

system [121]. It is synthesized in the liver, exported as a non-glycosylated protein, and is
present in the blood to regulate the colloidal osmotic pressure. Previous report shows that
the S-nitrosothiol fraction is largely composed o f the S-nitrosothiol adduct o f serum
albumin [122]. The levels o f S-nitroso-serum albumin change with inhibition o f nitric
oxide production in concert with changes in blood pressure [ 1 2 2 ].
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5.4.7

Cvtoskeleton Proteins
Actin is highly conserved protein which participates in a wide variety o f cellular

functions in eucaryotes, including muscle contraction, am eboid movement, cytokinesis,
and mitotic division [123]. Cytoplasmic actin is one o f the major classes o f actin. All
organisms thus far examined express a cytoplasmic actin form , which is usually utilized
to construct the cellular microfilaments [124],

5.5

C onclusions

These results present the first proteomic profiling o f S-nitrosylation related to
MQ exposure in colon cancer cells (HT-29 cells). The biotin switch technique is a viable
technique for identification o f S-nitrosylated proteins in this study. Certainly, based on
the study o f these results, a total o f 20 proteins were m odified by nitrosylation in M Qtreated HT-29 cells and at least 10 nitrosylated proteins were increased by exposure to
MQ. Among the 20 proteins, seventeen o f them are never reported in other systems. In
addition to identifying novel targets o f S-nitrosylation, these results provide new protein
targets that should facilitate future biom arker and therapy research.

CHAPTER 6

CONCLUSIONS AND FUTURE WORK

6.1

C onclusions

This dissertation provides a description o f technologies that enable studies aimed
at understanding the significance o f protein modification in colon cancer and A lzheim er’s
disease. The S-nitrosothiol level increases in both 200 //M M Q treated HT-29 cells and 5month-old AD Tg mice model monitored by commercial CGE-LIF machine and in-house
built 2D //-CE system. The fluorescence switch method, coupled with a commercial CE
machine, can detect 1.3 pM concentration o f nitrosylated proteins in nanogram amounts
o f proteins, which is the lowest LOD reported to date. This method also demonstrated its
capability in monitoring nitrosylation in both cell culture and tissue systems. Due to the
small sample need, it is envisioned that the m ethod can be extended to investigate protein
nitrosylation profiles in minuscule samples o f brain tissues and/or blood plasm a in the
disease progression o f AD transgenic mouse models.
The increasing o f the S-nitrosothiol level in both 200 //M MQ treated HT-29 cells
and 11-month-old AD Tg mice model is also monitored by an in-house built 2D //-CE
system. Nitrosylated proteins were profiled using a 2D //-CGE/MEEKC polymer
microchip and monitoring its expression using an LIF detector. The 2D //-CE device
achieved high peak capacity, which allows the separation o f a panel o f nitrosylated
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proteins. In addition, the ultrasensitive assay o f nitrosothiol derivatization and labeling
allowed for the monitoring o f these biomarkers even at a low abundance level.
Altogether, an oxidative-stress induced biom arker profiling was generated, and this
application could further serve as a fingerprint to determine AD disease phenotypes from
biological samples.
The identified nitrosylated proteins with an increase in nitrosylation, done by
proteomics, also provide the evidence to support the central hypothesis. These results
present the first proteomic profiling o f S-nitrosylation related to MQ exposure in colon
cancer cells (HT-29 cells). The biotin switch technique is a viable technique for
identification o f S-nitrosylated proteins in this study. A total o f 20 proteins were modified
by nitrosylation in MQ-treated HT-29 cells and at least 10 nitrosylated proteins were
increased by exposure to MQ. Among the 20 proteins, seventeen o f them are never
reported in other systems. In addition to identifying novel targets o f S-nitrosylation, these
results provide new protein targets that should facilitate future biomarker and therapy
research.

6.2

Future W ork

The methodologies developed in this dissertation could be extended to investigate
protein S-nitrosylation for all kinds o f tissues and blood in different animal models or
human beings. It is important to point out the potential application o f early disease
screening through combining these 3D landscapes o f biomarkers from the AD Tg mice
brain tissue o f different ages and gender with multivariate analysis. Furthermore, similar
applications may be found in investigating the etiologies o f diseases including
Alzheim er’s disease, Parkinson’s disease, diabetes and stroke. In addition, the in-house
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built 2D //-CE system has great potential for biomarker discovery by coupling with mass
spectrometry. This technique has a wide range o f applications in analysing other sub
populations o f proteomes, such as phosphorylation, carbonylation, nitration and others.
6.2.1

PCA Analysis for Future Direction
Principle component analysis (PCA) is one o f the m ost common techniques used

to bring out data patterns that are not easily identified in electrophoretic profiles in the
fields o f biological processes, polymer materials, and food products. It does so by
reducing the number o f dimensions (e.g. number o f data points in an electropherogram)
in multidimensional datasets to fewer dimensions (i.e. principle components, PC ’s), while
retaining the dataset’s variability. In PCA, each sample has scores associated with each
PC. The m ost important PCs can be used to define a coordinate system and their score
values represent each sample in the score plot. In the score plot, the closer the distance
between samples, the more similar they are in respect to the features represented by the
PCs selected for the score plot.
In this work, CGE-LIF electropherograms were used as fingerprints o f protein Snitrosylation. In order to have a better understanding o f age-associated change in
nitrosylation profiling o f the AD Tg mice model, PCA is needed to predict the
relationship between the nitrosylation and aging.
6.2.2

Estimating S-Nitrosvlation Levels
by Fluorescence Imaging
In the previous study, it has been demonstrated that S-nitrosylation levels o f

proteins increase in AD Tg mice brain tissue (Chapters 3 and 4). However, the exact
localization o f nitrosylated proteins within the brain is still unknown (Figure 6-1). Future
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studies should investigate a methodology to localize the S-nitrosylated proteins needed in
AD Tg mice brain tissues.

P ro te in Sn itro s y la tio n

/

A D Tg m i c e
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Figure 6-1: General picture o f the protein S-nitrosylation study in AD Tg mice brain
tissue and MQ treated HT-29 cells.

6.2.3

Integrated M icrofluidic Systems
with Proteomics
Microchip separation technology has great potential to integrate with proteomics

since it has been successfully used in the CE study. By integrating various devices into a
single microchip, dead volumes are minimized and total analysis time is reduced.
The in-house built 2D-/rCE system has great potential for biom arker discovery by
coupling with mass spectrometry. In addition, this technique has a wide range o f
applications in analysing other sub-populations o f proteomes, such as phosphorylation,
carbonylation, nitration and others.
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